rfhg_129176.1

Basic information about the TSS

---

TSS ID: rfhg_129176.1 Species: human Chr: chr10		Start: 100347141 End: 100347153 Strand: +
Source datasets	PRJNA548673
Protocol	ReCappable-seq
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2382170,EH38E1493453)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC062303:-12 GeneID: 6319 HGNC/MGI_ID: HGNC:10571 UniProt_ID: Nearer transcript ids and distances: AB032261:-17 ENST00000370355.3:80 NM_005063.5:80 AK312312:80 AB208982:105 LF345707:110 MA581284:110 AF097514:117 AK222862:145 Y13647:145 BC005807:175 LF345708:325 MA581285:325 AB529038:352 KJ897520:352 view more...

Gene_name: stearoyl-CoA desaturase Gene_symbol: SCD Gene_synonyms: FADS5 SCD1 Gene_source: HGNC:10571

TATA-Box annotation

---

Distance to TSS:	-86
Nearest PromoterID:	NM_005063
Entrez ID:	6319
Nearest Unigene:	Hs.558396
Nearest Refseq:	NM_005063
Nearest Ensembl:	ENSG00000099194
Gene Name:	stearoyl-CoA desaturase
Gene Alias:	FADS5|MSTP008|SCD1|SCDOS|hSCD1
Gene Type:	protein-coding
CpG%:	0.166667
GC%:	0.769231
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SCD p2@SCD p3@SCD p4@SCD p5@SCD p6@SCD p8@SCD p9@SCD
Sample		p1@SCD	p2@SCD	p3@SCD	p4@SCD	p5@SCD	p6@SCD	p8@SCD	p9@SCD
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	69.35	13.05	1.17	3.90	5.06	0.58	0.39	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	66.56	17.80	1.21	5.26	6.27	0.20	0.40	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	62.50	14.08	1.54	3.86	5.40	0.39	0.58	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	55.72	9.98	1.66	3.53	4.99	0.62	0.62	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	50.62	11.92	0.90	3.15	6.07	0.45	0.67	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	65.51	13.57	1.36	4.46	4.85	0.19	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	31.81	15.69	0.44	4.58	3.49	1.09	0.87	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	32.94	13.08	0.73	3.88	1.94	0.00	0.73	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	31.42	15.82	0.21	2.99	2.78	0.00	0.64	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	11.59	13.33	0.00	2.90	3.48	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	11.32	13.34	0.00	2.43	1.21	0.00	1.21	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	15.86	11.38	0.81	2.03	0.81	0.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	14.35	12.25	1.77	5.00	2.10	0.81	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.08	11.58	2.26	5.41	1.80	0.90	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	14.93	8.34	0.66	1.98	1.76	0.00	0.44	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	15.84	8.30	2.01	5.53	0.00	1.01	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	14.20	8.52	2.18	3.28	1.09	0.66	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	14.76	8.44	0.84	3.37	0.84	0.42	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	15.46	8.53	0.53	3.73	1.07	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	11.88	11.43	2.11	3.16	1.20	0.45	0.15	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	19.25	10.02	0.80	2.81	1.74	0.53	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	15.02	8.80	4.83	4.66	1.38	1.04	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	14.86	8.40	2.46	2.46	1.42	0.78	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	14.07	8.25	2.67	3.15	0.49	1.21	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	18.32	9.80	5.16	3.35	2.84	2.32	0.52	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	18.67	8.86	4.11	1.58	0.95	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	21.98	7.14	2.20	6.04	2.75	0.55	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	22.63	11.08	8.49	4.48	2.83	2.12	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	16.15	10.66	4.68	4.04	2.91	1.45	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	17.92	10.13	5.25	3.08	2.90	1.09	0.90	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	18.00	6.70	6.07	3.98	1.67	1.26	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	22.27	8.40	7.03	3.52	2.54	1.56	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	23.42	10.13	6.54	5.70	2.11	2.11	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	17.65	9.57	3.46	4.45	1.98	1.48	0.49	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	18.14	11.22	5.42	4.11	1.68	2.06	0.37	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	12.26	8.24	5.37	3.45	1.72	0.96	0.38	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	15.53	8.79	6.13	2.04	1.64	1.23	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	15.11	7.66	4.03	3.43	2.42	1.41	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	14.86	8.64	4.05	4.05	1.62	2.16	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	15.60	11.04	5.04	1.44	1.68	1.20	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.94	8.70	5.41	2.82	1.18	0.71	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	18.30	6.73	4.39	3.37	0.59	1.32	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	15.18	8.22	6.33	1.69	2.32	1.90	0.42	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	18.01	11.89	4.90	3.15	2.62	1.92	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	20.68	8.03	4.82	2.81	2.81	1.20	0.80	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	18.61	9.07	8.38	3.26	1.63	1.16	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.95	7.68	6.24	3.12	0.72	1.44	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	18.48	6.56	7.45	2.98	2.09	1.49	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	18.19	9.34	8.38	1.68	1.44	1.20	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	17.19	11.32	9.50	3.24	2.22	2.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	25.41	6.97	7.17	2.66	2.05	1.02	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	23.79	9.34	7.78	2.89	1.33	2.89	0.44	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	18.45	10.29	8.52	2.48	0.71	1.06	0.35	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	19.22	9.28	6.30	2.98	0.66	0.66	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.94	8.39	3.36	5.03	1.68	0.84	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	22.04	10.10	5.51	3.67	1.38	0.92	0.46	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	22.04	11.34	6.48	0.65	2.27	0.97	0.65	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	21.52	9.31	7.39	1.93	0.96	1.28	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	25.46	11.63	7.86	1.89	1.57	2.51	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	21.86	16.22	7.05	0.71	2.12	1.41	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	21.87	9.53	6.17	4.49	0.00	1.12	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	44.58	17.52	15.92	4.78	3.18	3.18	1.59	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	51.64	12.57	10.53	5.78	3.40	2.72	0.00	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	40.62	17.22	13.97	4.87	3.57	1.30	2.27	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	46.50	19.52	9.23	4.97	2.48	1.42	0.00	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	0.00	7.90	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	115.05	35.59	41.44	9.75	4.88	0.49	2.44	4.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	138.35	25.79	43.14	12.40	4.46	3.97	2.98	6.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	138.39	29.55	40.34	8.91	4.69	2.35	1.88	5.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	222.56	42.72	101.67	9.27	5.63	3.97	4.64	4.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	185.91	27.22	90.33	12.99	7.42	2.78	3.09	8.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	173.36	36.38	88.05	15.90	9.48	3.36	2.75	7.03
Adipocyte - breast, donor1	11376-118A8	19.96	4.91	49.73	3.80	1.58	2.53	2.38	0.32
Adipocyte - breast, donor2	11327-117E4	19.89	8.02	1291.92	4.81	0.80	10.43	51.02	89.20
Adipocyte - omental, donor1	11473-119C6	22.01	7.63	420.61	5.09	2.29	7.38	10.18	6.87
Adipocyte - omental, donor2	11474-119C7	4.48	3.74	323.66	0.75	0.00	1.49	5.98	5.23
Adipocyte - omental, donor3	11475-119C8	18.09	2.34	1292.79	3.35	3.68	4.02	18.42	20.43
Adipocyte - perirenal, donor1	11476-119C9	14.67	3.83	27.43	4.47	0.64	1.28	0.00	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	19.79	7.70	2411.22	3.30	1.10	12.09	36.28	17.59
Adipocyte - subcutaneous, donor2	11336-117F4	38.39	6.77	240.72	6.32	2.71	6.32	7.23	4.06
Adipocyte - subcutaneous, donor3	11408-118E4	15.12	5.56	1043.00	4.69	2.09	14.42	18.25	25.72
Adipocyte differentiation, day04, donor1	13019-139D4	201.83	26.79	825.51	23.47	12.91	38.33	14.28	13.10
Adipocyte differentiation, day04, donor2	13022-139D7	220.32	15.96	415.67	11.07	6.69	14.93	5.66	8.49
Adipocyte differentiation, day04, donor3	13025-139E1	229.15	15.61	938.35	20.35	9.76	34.01	11.71	13.38
Adipocyte differentiation, day04, donor4	13028-139E4	169.29	13.52	2649.26	16.46	9.99	39.38	9.40	14.11
Adipocyte differentiation, day08, donor1	13020-139D5	88.88	17.53	3133.03	17.53	7.56	53.25	45.85	41.74
Adipocyte differentiation, day08, donor2	13023-139D8	166.54	10.01	1392.36	17.11	5.49	30.34	12.59	18.40
Adipocyte differentiation, day08, donor3	13026-139E2	105.04	14.40	1625.69	12.80	7.46	28.26	26.13	47.45
Adipocyte differentiation, day08, donor4	13029-139E5	104.61	4.45	5692.90	15.58	7.23	53.97	39.51	40.62
Adipocyte differentiation, day12, donor1	13021-139D6	59.47	14.56	13422.91	12.48	2.91	36.60	65.30	79.85
Adipocyte differentiation, day12, donor2	13024-139D9	126.84	12.81	1998.02	13.31	6.03	25.12	23.86	39.94
Adipocyte differentiation, day12, donor3	13027-139E3	83.12	10.80	4212.30	13.74	4.91	30.76	47.78	89.34
Adipocyte differentiation, day12, donor4	13030-139E6	92.25	17.96	8435.38	13.40	3.65	51.46	53.59	83.12
Alveolar Epithelial Cells, donor1	11510-119G7	34.25	37.57	0.66	2.87	2.65	0.44	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	30.48	21.16	0.36	3.23	1.08	0.00	0.72	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	28.75	20.37	5.99	9.58	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	342.72	28.07	5.94	19.07	8.64	1.62	1.62	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	165.68	15.06	10.04	10.04	1.67	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	236.68	29.58	4.31	13.56	5.96	1.85	1.85	0.82
Anulus Pulposus Cell, donor1	11248-116E6	89.82	16.82	37.42	14.65	7.78	4.81	2.17	0.69
Anulus Pulposus Cell, donor2	11463-119B5	57.31	7.84	46.78	7.35	6.37	1.96	0.98	1.71
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	21.12	5.84	117.72	2.25	1.80	0.90	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	11.72	5.21	1.30	3.04	0.43	0.00	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	4.28	0.00	2.14	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	15.54	7.47	17.64	2.69	1.49	0.30	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	5.06	1.26	0.00	1.26	1.26	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.90	4.62	0.00	1.32	0.00	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	9.75	4.55	4.55	1.95	0.32	0.97	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	12.14	2.43	0.00	0.49	1.94	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	2.97	1.19	0.59	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	6.40	3.01	9.79	2.26	0.38	0.38	0.00	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.16	2.90	0.00	2.90	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	0.00	0.00	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	10.87	4.12	0.49	1.65	0.33	0.16	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	2.73	1.36	0.00	1.36	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	11.16	2.71	0.60	0.75	1.06	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.18	6.97	43.40	1.07	2.14	0.00	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.31	3.97	0.57	1.51	0.57	0.94	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	11.76	5.35	0.27	1.87	1.34	0.00	0.27	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	13.66	5.85	14.63	6.83	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	8.29	3.32	0.83	1.66	1.00	0.50	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	6.00	0.00	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	31.86	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	8.75	4.80	0.34	1.89	0.00	0.34	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	13.59	4.85	0.49	4.85	1.94	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	13.28	3.42	1.14	1.14	1.14	0.00	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	10.90	3.63	0.00	4.85	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	7.41	2.28	1.71	1.71	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	11.54	5.99	0.43	1.92	1.50	0.43	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	10.84	4.90	0.77	2.32	0.77	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	8.91	7.04	0.00	2.82	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.97	4.50	0.96	1.61	0.96	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.13	2.14	0.71	1.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	9.94	4.68	0.58	0.58	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.33	3.91	0.00	1.51	0.60	0.30	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	5.94	0.00	1.19	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	10.17	3.56	1.02	3.56	2.03	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	10.70	6.37	0.25	1.02	0.51	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	7.62	6.35	0.64	1.91	0.64	0.00	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.49	5.18	0.00	3.02	0.43	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	10.58	4.02	1.27	2.12	1.27	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	8.70	2.32	0.00	1.74	0.87	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	10.39	1.89	0.00	1.89	3.78	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	11.02	5.76	0.51	2.37	0.85	0.17	0.00	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	2.32	0.00	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	2.11	2.11	2.11	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.86	3.22	0.64	1.29	1.07	0.43	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.62	3.61	0.00	0.60	0.60	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	9.48	1.46	0.00	0.73	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	10.57	5.52	0.92	1.15	0.46	0.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	7.65	2.55	0.00	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	7.63	1.78	0.00	1.27	0.00	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	9.50	6.40	1.03	2.06	0.62	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	6.43	2.75	0.92	1.84	0.92	0.31	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	6.21	1.43	0.48	1.43	1.43	0.00	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.53	3.77	0.44	2.00	1.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	3.05	0.00	1.53	1.53	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.86	3.88	0.55	1.11	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	7.41	5.83	0.26	1.32	0.79	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	6.91	2.91	0.73	1.45	0.73	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	366.73	55.27	34.63	14.00	30.21	3.32	2.58	0.74
Astrocyte - cerebellum, donor2	11580-120F5	205.22	44.33	121.87	10.44	18.66	6.68	1.71	5.48
Astrocyte - cerebellum, donor3	11661-122F5	132.77	33.77	26.85	9.23	10.91	7.13	1.26	3.36
Astrocyte - cerebral cortex, donor1	11235-116D2	111.20	46.36	5.58	13.59	6.97	3.49	1.74	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	144.14	62.44	5.66	13.43	12.29	1.78	3.24	3.07
Astrocyte - cerebral cortex, donor3	11392-118C6	169.89	69.81	23.42	13.28	14.77	3.13	3.43	3.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	108.26	49.54	0.69	16.86	11.47	0.69	0.46	4.24
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	96.72	47.61	0.38	16.54	10.27	0.50	0.88	3.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	110.50	47.79	0.11	18.66	9.79	0.57	1.02	1.25
Basophils, donor1	12241-129G9	1.83	1.83	0.26	0.26	0.00	0.52	0.00	0.00
Basophils, donor2	12242-129H1	2.16	1.08	0.00	0.72	0.00	0.36	0.00	0.00
Basophils, donor3	12243-129H2	3.09	2.94	1.91	1.03	0.44	0.15	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	160.62	29.97	9.06	13.15	5.17	1.94	1.08	1.29
Bronchial Epithelial Cell, donor2	11591-120G7	56.23	19.20	17.83	8.69	4.11	0.00	1.83	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	265.42	21.52	28.69	28.69	7.17	7.17	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	97.91	21.34	2.51	5.65	2.51	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	142.03	45.96	29.74	13.52	7.69	1.25	1.25	3.12
Bronchial Epithelial Cell, donor6	11461-119B3	72.77	28.79	8.98	9.21	4.38	0.69	1.61	3.22
Bronchial Epithelial Cell, donor7	11769-123I5	195.60	39.95	54.16	16.55	6.66	2.88	2.16	6.12
Burkitt's lymphoma cell line:DAUDI	10422-106C8	22.26	14.53	0.00	11.85	4.12	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	146.73	47.28	0.00	17.93	12.11	0.70	1.16	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	7.35	5.44	0.00	1.92	0.64	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	2.82	1.69	0.00	0.56	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	1.86	5.01	0.00	0.19	0.19	0.00	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	1.54	2.41	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	22.64	17.27	0.00	6.23	3.40	0.28	0.57	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	62.55	32.98	0.38	15.54	3.79	0.76	0.76	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	45.69	24.33	0.00	14.79	2.63	0.00	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	0.43	0.14	0.14	0.14	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	0.60	0.30	0.00	0.30	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	0.24	0.47	0.00	0.47	0.00	0.00	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.50	0.17	0.00	0.17	0.17	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1.10	0.55	0.28	0.28	0.00	0.00	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.74	0.50	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.00	0.20	0.00	0.20	0.20	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.18	0.71	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	0.53	0.53	0.00	0.00	0.53	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.45	0.74	0.00	0.15	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	0.60	0.60	0.20	0.00	0.20	0.00	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.42	0.42	0.00	0.21	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.00	0.23	0.00	0.45	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.44	0.44	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.27	0.27	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	0.17	1.05	0.00	0.35	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.00	0.84	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.00	0.18	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.35	0.35	0.00	0.35	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.17	0.35	0.00	0.17	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.37	0.00	0.00	0.37	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	0.22	0.43	0.00	0.22	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3.69	1.23	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.23	0.46	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.00	0.23	0.00	0.23	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.00	0.46	0.00	0.00	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	0.00	0.47	0.00	0.00	0.16	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	0.17	0.17	0.00	0.17	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	0.22	0.22	0.00	0.00	0.22	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	2.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.00	2.03	0.00	0.68	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	0.00	0.00	1.04	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.00	0.53	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	1.61	1.07	0.00	0.54	0.54	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.70	0.00	0.00	0.00	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.78	0.78	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	2.90	0.73	0.00	0.73	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	2.02	0.50	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	6.87	2.42	0.00	0.40	1.21	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	3.20	3.60	0.00	0.40	0.40	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	17.07	5.02	0.00	5.02	3.01	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	13.48	3.93	0.00	1.69	0.00	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	6.39	3.38	0.00	2.25	1.50	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	8.34	4.96	0.00	1.80	2.03	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	1.07	0.71	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	1.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	0.91	0.61	0.00	0.00	0.00	0.00	0.00	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	13.02	4.08	0.00	4.08	1.28	0.00	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	11.68	5.17	0.00	1.57	2.25	0.00	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	17.54	2.59	0.00	2.01	1.44	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.00	0.47	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	8.09	4.05	0.00	1.01	0.72	0.00	0.29	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	7.29	4.41	0.00	2.37	1.69	0.34	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	7.74	4.67	0.00	1.93	1.61	0.00	0.32	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.90	0.45	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	13.49	5.48	0.00	0.42	2.95	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	10.60	1.87	0.00	1.45	1.66	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	11.03	2.67	0.00	2.00	2.67	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.54	0.27	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	0.54	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	31.34	9.46	0.00	3.52	2.78	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	11.05	5.42	0.00	1.52	0.87	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	18.49	4.41	0.00	1.89	2.73	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.00	1.01	0.00	0.00	0.00	0.00	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.43	0.00	0.00	0.43	0.43	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	2.18	0.44	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	1.48	1.48	0.00	0.00	0.99	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	0.92	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	2.79	1.40	0.00	2.79	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	0.28	1.38	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	2.21	0.49	0.00	0.49	0.25	0.00	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	1.54	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	1.79	1.79	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	0.00	1.38	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	4.26	3.93	0.00	1.31	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	4.88	3.38	0.38	0.75	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	2.78	3.79	1.01	0.25	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	67.90	9.18	0.69	2.75	2.52	0.69	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	59.67	9.59	1.68	6.23	2.64	0.72	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	71.13	4.65	1.92	4.92	4.65	0.55	0.00	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	66.35	5.10	0.60	4.80	3.00	0.00	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	57.60	10.56	1.20	2.64	3.60	1.20	0.00	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	58.67	5.46	1.14	4.32	2.50	0.45	0.23	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	59.97	7.39	0.65	2.61	1.30	0.00	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	67.91	3.95	1.32	4.47	3.42	0.79	0.79	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	57.22	6.33	0.47	2.35	1.88	0.70	0.23	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	102.03	6.64	0.60	6.64	3.32	0.30	0.60	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	91.51	10.46	2.91	4.36	4.65	0.29	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	94.32	13.32	1.07	5.33	2.40	1.33	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	81.42	6.57	4.38	3.50	6.13	0.88	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	74.23	11.84	7.74	9.11	3.19	0.91	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	110.39	8.95	9.70	2.98	5.22	2.24	0.75	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	46.82	7.20	1.08	2.16	2.52	0.72	1.08	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	39.42	5.75	1.15	0.86	2.59	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	42.19	6.36	1.18	2.36	2.59	0.24	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	47.22	8.56	0.95	3.49	3.49	0.32	0.32	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	59.97	9.84	0.31	2.15	1.23	0.00	0.00	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	58.67	9.94	0.96	3.21	2.56	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	68.84	10.71	1.15	1.91	4.21	0.00	0.00	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	58.33	5.52	0.39	5.52	1.97	0.39	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	65.05	12.86	0.00	4.54	6.81	1.51	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	22.48	4.01	1.61	2.41	0.80	0.80	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	29.38	9.09	2.10	2.10	1.40	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	38.07	9.02	1.00	1.00	1.00	1.00	1.00	2.00
Cardiac Myocyte, donor1	11525-119I4	45.69	7.31	65.80	14.62	3.66	9.14	0.00	3.66
Cardiac Myocyte, donor2	11605-120I3	129.45	34.09	42.49	9.39	2.47	4.45	0.99	4.94
Cardiac Myocyte, donor3	11686-122I3	66.61	32.10	66.19	8.00	4.31	7.16	1.05	0.42
Chondrocyte - de diff, donor1	11261-116G1	0.69	1.73	0.00	0.00	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	1.07	0.71	0.00	0.36	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	1.48	1.25	0.11	0.34	0.23	0.11	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	47.45	23.28	5.37	4.48	0.90	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	4.85	13.35	0.81	0.81	0.00	0.81	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	342.67	39.48	19.28	14.57	27.08	5.74	2.87	1.49
Ciliary Epithelial Cells, donor2	11323-117D9	223.17	30.14	33.13	11.33	18.17	4.28	4.49	6.84
Ciliary Epithelial Cells, donor3	11399-118D4	226.38	29.12	39.65	10.89	18.67	6.99	4.07	3.54
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	55.66	29.80	9.90	8.34	4.40	1.47	1.28	1.28
Corneal Epithelial Cells, donor1	11526-119I5	174.12	34.91	10.76	17.79	6.37	0.66	1.10	1.54
Corneal Epithelial Cells, donor2	11606-120I4	211.59	30.72	13.65	18.20	3.41	3.41	1.14	5.69
Corneal Epithelial Cells, donor3	11687-122I4	167.69	42.18	14.83	13.80	8.18	2.05	1.28	3.07
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	11.06	8.25	0.00	1.49	1.32	0.00	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	10.41	7.57	0.00	1.89	0.32	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	13.80	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	24.19	14.04	0.86	2.27	2.27	0.22	0.43	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	5.12	3.42	0.00	0.00	2.39	0.00	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	4.57	5.88	0.00	0.65	0.65	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	2.42	3.39	0.00	0.97	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	31.02	25.68	0.83	5.34	1.50	0.50	0.67	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	11.15	7.04	3.52	3.52	0.59	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	34.78	23.75	0.57	6.79	1.70	0.00	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	12.98	11.40	0.39	5.90	0.79	1.57	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	3.49	6.11	0.00	0.58	0.58	0.00	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	14.59	19.76	0.24	2.82	1.41	0.24	0.47	0.47
Endothelial Cells - Artery, donor3	11413-118E9	7.89	9.12	0.18	1.75	0.88	0.88	0.00	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	25.27	8.20	3.55	3.55	1.99	0.89	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	30.73	13.39	0.91	4.26	1.22	1.52	0.91	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	33.26	12.12	0.85	8.18	1.41	0.28	1.41	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	33.28	13.07	0.59	6.24	1.49	0.89	0.89	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	1.04	2.60	0.52	0.52	1.56	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	8.93	6.81	3.26	2.69	1.42	0.99	0.43	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	31.21	15.60	0.40	6.40	1.60	0.00	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	4.19	6.29	0.00	0.52	1.05	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	52.93	46.47	1.74	14.29	4.35	1.74	1.12	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	53.88	54.32	2.39	12.38	3.69	1.52	0.87	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	69.73	68.03	3.66	15.75	3.66	2.20	0.85	0.85
Endothelial Cells - Vein, donor1	11267-116G7	27.30	12.51	0.00	2.28	1.14	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	25.15	23.75	0.00	6.99	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	21.20	25.44	2.51	5.02	0.79	1.10	0.63	0.63
Eosinophils, donor1	12244-129H3	30.49	0.00	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	10.70	0.00	0.00	0.00	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	156.86	51.80	16.13	14.17	4.89	1.71	0.98	1.47
Esophageal Epithelial Cells, donor2	11587-120G3	97.77	16.64	8.32	10.40	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	195.23	32.54	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	19.29	6.16	4.93	1.64	2.05	0.82	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.53	3.39	9.63	2.41	1.64	0.44	0.44	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	5.85	4.44	1.19	1.30	0.22	0.76	0.22	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	15.77	11.16	2.91	3.52	1.58	2.30	0.73	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	32.89	11.60	18.29	5.60	1.91	1.23	0.00	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	33.75	17.72	13.50	5.27	3.16	2.11	1.37	2.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	86.42	22.40	44.53	15.55	6.06	2.37	1.58	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	32.22	18.60	24.91	5.65	2.66	2.66	1.00	2.33
Fibroblast - Cardiac, donor1	11268-116G8	14.97	8.62	4.54	2.27	0.91	0.45	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	24.25	9.10	1.52	2.27	1.52	0.00	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	17.51	10.88	0.32	2.84	1.26	0.32	0.32	0.79
Fibroblast - Cardiac, donor4	11452-119A3	116.39	25.46	29.70	12.12	6.37	14.85	2.12	2.42
Fibroblast - Cardiac, donor5	11456-119A7	61.80	19.67	23.73	10.79	2.79	2.54	0.89	1.65
Fibroblast - Cardiac, donor6	11460-119B2	71.86	22.89	18.34	9.85	4.09	4.09	2.12	4.40
Fibroblast - Choroid Plexus, donor1	11492-119E7	397.68	15.27	54.80	17.55	31.62	8.31	2.28	1.21
Fibroblast - Choroid Plexus, donor2	11572-120E6	132.02	4.75	70.32	5.61	11.22	4.31	0.86	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	316.40	46.87	43.94	16.11	20.51	11.72	1.46	5.86
Fibroblast - Conjunctival, donor1	11531-120A1	190.28	94.33	22.60	22.14	7.84	3.46	1.85	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	145.86	13.40	97.86	36.97	12.21	13.57	6.11	1.87
Fibroblast - Dermal, donor1	11269-116G9	46.25	8.69	85.23	7.75	3.99	8.22	1.64	1.41
Fibroblast - Dermal, donor2	11346-117G5	59.90	12.26	12.26	3.77	2.83	3.77	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	56.45	10.76	70.84	7.86	3.75	9.43	1.33	1.33
Fibroblast - Dermal, donor4	11450-119A1	180.99	63.76	40.02	22.50	12.32	2.83	1.92	6.90
Fibroblast - Dermal, donor5	11454-119A5	233.94	46.93	45.88	24.07	16.57	2.97	2.44	5.06
Fibroblast - Dermal, donor6	11458-119A9	282.29	55.71	21.93	23.71	21.44	2.92	3.09	5.04
Fibroblast - Gingival, donor1	11237-116D4	140.56	37.27	128.27	13.53	6.87	11.24	1.04	2.08
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	3.93	4.72	0.00	2.88	1.05	0.26	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	166.18	49.81	26.36	15.95	8.04	3.03	1.84	4.74
Fibroblast - Gingival, donor3	11394-118C8	126.66	44.19	72.13	19.92	7.64	12.47	1.55	5.90
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	103.89	37.40	27.01	17.66	12.47	3.12	3.12	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	39.82	17.09	5.29	6.87	4.58	0.35	1.06	1.41
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	19.49	9.20	0.78	2.96	2.81	0.94	0.16	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	40.16	14.88	2.57	5.81	5.27	1.08	0.81	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	23.64	10.94	0.35	3.53	2.47	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	78.53	15.50	9.21	6.73	7.75	2.19	0.88	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	16.09	3.41	0.68	1.36	0.82	0.68	0.14	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	14.70	6.14	0.22	1.86	1.32	0.22	0.00	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	36.54	10.86	1.32	9.68	2.93	1.32	0.73	0.15
Fibroblast - Lung, donor1	11270-116H1	72.05	24.47	36.70	2.72	2.72	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	83.56	31.34	29.84	8.95	2.98	7.46	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	67.53	40.52	42.21	8.23	4.22	7.39	1.90	2.53
Fibroblast - Lymphatic, donor1	11506-119G3	544.80	91.63	99.96	46.65	29.16	16.66	2.50	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	202.80	16.78	106.30	13.99	6.99	13.99	1.40	5.59
Fibroblast - Lymphatic, donor3	11667-122G2	80.04	19.31	45.90	9.80	2.52	2.80	2.52	2.24
Fibroblast - Mammary, donor1	11540-120B1	516.39	117.33	43.44	41.81	22.73	8.53	1.62	3.25
Fibroblast - Mammary, donor2	11620-122A9	283.59	47.93	91.87	3.99	11.98	0.00	3.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	172.73	59.56	202.51	35.74	0.00	17.87	5.96	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	141.41	55.09	24.25	17.85	9.89	3.10	1.75	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	201.13	107.69	26.39	29.88	13.50	4.40	2.28	11.53
Fibroblast - Periodontal Ligament, donor3	11395-118C9	253.05	100.67	29.68	22.64	19.28	4.28	0.92	1.53
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	91.59	34.73	24.04	7.63	1.53	2.67	0.38	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	27.00	10.26	1.08	2.97	3.78	0.81	0.81	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	49.17	18.32	4.52	6.96	4.52	1.39	1.04	1.04
Fibroblast - Pulmonary Artery, donor1	11250-116E8	23.99	13.37	1.22	3.54	1.11	1.22	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	374.89	164.18	55.06	28.24	10.57	7.31	1.63	4.47
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	232.53	16.04	124.29	16.04	16.04	8.69	0.67	4.01
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	140.75	14.23	46.65	10.67	9.88	12.26	2.37	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	52.99	7.94	0.79	8.73	2.98	0.20	0.20	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	10.66	3.73	0.36	1.95	0.89	0.00	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	16.56	7.10	0.79	2.76	1.97	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	44.53	15.34	1.81	9.33	4.51	0.00	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	19.76	9.61	0.54	4.64	2.27	0.43	0.00	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	31.89	7.34	0.51	4.81	2.78	0.76	0.51	0.25
Fibroblast - skin normal, donor1	11553-120C5	21.99	7.06	0.82	1.97	1.15	1.15	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	54.14	21.05	8.02	7.42	4.01	2.81	0.80	0.20
Fibroblast - skin normal, donor2	11561-120D4	20.09	12.96	0.80	3.42	2.21	1.31	0.30	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	52.29	9.97	3.32	6.04	3.02	0.91	0.00	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	18.06	7.37	0.58	3.65	2.24	0.25	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	20.51	9.23	0.85	6.15	2.05	0.85	0.17	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	65.03	16.42	3.28	8.54	3.61	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	15.55	8.42	0.43	3.52	1.07	0.32	0.11	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	14.00	5.57	0.67	1.86	0.84	0.17	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	11.92	3.61	1.57	2.51	0.31	0.16	0.16	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	76.69	3.49	13.94	2.61	1.74	0.87	1.74	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	209.94	21.50	13.52	20.46	6.93	3.29	3.64	1.21
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	191.54	39.82	7.03	17.44	7.55	0.78	4.94	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	269.31	41.65	14.31	18.91	9.96	4.09	2.30	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	168.42	30.62	1.53	21.44	19.14	0.00	1.53	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	174.83	24.88	3.19	24.88	23.61	1.28	3.19	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	172.58	35.09	0.29	32.52	38.23	1.43	3.42	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	37.78	31.71	0.28	15.17	12.96	0.28	1.65	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	77.86	26.49	0.00	15.53	13.24	1.60	2.05	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	133.54	36.46	0.79	26.75	32.30	0.40	1.78	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	44.67	24.05	0.00	12.95	10.31	0.26	1.32	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	107.95	27.72	0.33	15.98	14.35	1.30	4.89	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	144.61	26.09	0.88	29.19	32.28	1.33	0.44	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	82.81	43.10	0.99	20.77	12.86	0.28	1.70	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	76.47	34.97	1.72	14.65	11.45	0.37	1.11	2.09
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	65.81	27.67	0.27	13.70	12.63	0.54	1.61	1.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	33.45	21.68	0.25	11.40	5.20	0.25	0.25	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	33.22	29.07	0.28	11.07	7.61	0.14	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	44.52	22.57	0.61	10.98	6.51	0.41	0.81	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	53.17	15.97	0.91	7.76	7.07	0.23	0.68	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	44.59	20.06	0.25	10.96	6.98	0.12	0.87	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	71.26	28.85	0.44	11.37	8.96	0.22	0.66	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	52.30	19.80	0.30	11.82	6.50	0.00	0.89	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	60.88	23.21	0.16	10.81	6.68	0.16	0.48	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	52.50	28.60	0.00	10.05	6.70	0.22	1.12	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	77.63	22.38	0.81	14.72	11.90	0.40	0.40	2.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	69.72	27.82	0.51	10.18	8.48	0.00	0.85	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	96.56	22.43	0.62	17.38	10.37	0.09	1.60	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	126.32	36.73	0.52	27.89	16.75	0.52	2.19	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	121.25	30.40	0.34	21.01	11.27	0.17	1.20	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	84.43	27.88	0.33	14.38	10.51	0.22	0.89	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	101.33	19.05	0.83	15.89	12.15	0.67	1.58	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	110.46	17.97	0.61	13.27	10.00	0.41	1.84	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	94.69	18.98	0.21	15.68	8.46	0.00	3.09	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	89.93	25.48	0.58	17.29	12.34	0.58	1.38	1.15
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	124.91	26.18	1.00	18.84	13.01	0.67	3.50	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	65.91	22.92	0.22	15.43	9.70	0.22	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	54.49	25.71	0.49	9.96	9.22	0.12	1.72	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	130.00	26.42	2.11	11.02	5.84	1.30	2.76	1.78
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	77.29	23.73	0.32	15.72	8.02	0.32	0.32	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	68.41	20.75	0.95	10.23	8.15	0.38	0.95	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	139.19	26.42	1.90	15.66	8.23	0.79	6.01	1.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	86.66	24.63	0.30	10.95	8.82	0.91	0.91	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	58.54	19.55	0.63	10.35	5.75	0.31	0.63	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	160.93	34.25	2.42	19.76	9.44	1.76	10.10	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	79.40	19.08	0.56	8.98	8.70	0.56	1.12	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	93.33	15.28	0.83	10.09	7.41	0.46	1.39	2.13
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	160.71	17.65	3.48	12.57	7.22	1.60	5.62	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	107.26	11.93	1.38	13.62	7.34	1.68	0.77	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	93.14	15.67	1.55	9.97	6.74	0.39	2.46	1.30
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	174.57	29.55	1.36	18.70	7.59	0.81	8.67	1.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	98.44	18.44	0.55	12.72	7.37	0.55	1.47	2.21
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	71.72	13.82	0.88	10.53	7.02	0.88	1.10	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	341.16	64.46	4.96	34.71	17.85	7.93	13.88	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	98.01	14.38	1.45	8.57	6.20	0.79	1.45	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	108.75	16.34	3.43	9.48	4.64	1.21	1.61	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	236.11	82.09	1.02	39.39	17.03	1.27	9.40	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	74.85	45.19	0.20	27.87	11.15	0.20	1.59	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	27.73	37.59	0.46	12.63	7.86	0.31	1.39	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	60.97	41.12	0.00	18.21	14.32	0.00	1.23	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	180.25	22.22	0.63	23.78	27.85	0.63	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	161.34	19.78	0.00	18.93	20.06	0.00	0.28	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	158.65	29.06	0.92	16.14	24.44	0.00	0.92	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	106.42	37.12	2.47	4.95	9.90	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	146.60	22.43	1.55	12.76	15.09	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	157.24	19.25	0.00	19.25	8.02	1.60	3.21	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	123.46	33.04	5.22	6.96	12.17	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	181.29	17.58	0.98	12.37	15.62	0.65	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	181.19	18.12	0.41	14.00	13.59	1.65	1.65	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	176.61	46.65	6.66	19.99	23.33	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	192.96	17.34	1.12	13.98	16.22	0.28	1.12	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	211.47	17.00	2.61	16.02	18.96	0.65	2.29	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	223.13	19.29	1.68	14.26	31.88	1.68	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	216.61	18.77	0.00	13.04	19.40	1.27	1.91	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	239.80	21.40	2.38	21.40	25.47	0.34	1.70	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	192.11	25.06	2.09	14.62	29.23	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	260.01	24.05	3.44	21.76	27.49	0.57	2.29	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	191.21	21.61	1.48	17.46	19.53	0.30	2.37	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	159.25	22.02	11.86	10.16	13.55	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	232.78	20.30	2.07	25.27	13.67	0.83	1.66	3.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	329.54	29.23	2.53	24.85	21.63	1.61	2.30	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	200.20	21.07	10.54	31.61	10.54	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	207.97	19.99	3.46	20.37	15.76	2.31	2.31	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	158.10	17.60	2.61	17.28	12.39	1.30	1.30	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	109.02	18.73	10.70	12.04	6.02	2.68	1.34	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	159.89	30.44	4.62	26.58	15.03	1.16	4.24	3.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	165.01	29.10	2.40	19.17	12.67	1.03	2.40	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	144.12	14.91	2.48	9.94	12.42	2.48	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	197.23	30.20	5.19	28.78	17.93	0.94	0.94	4.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	125.53	28.97	3.62	19.92	5.43	3.62	4.83	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	117.00	27.47	5.09	18.31	10.17	1.02	3.56	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	180.67	31.11	6.78	22.73	16.75	1.99	3.59	2.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	184.02	25.65	10.85	28.12	12.33	1.97	4.44	3.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	107.42	22.43	8.26	15.35	3.54	2.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	154.03	25.67	1.17	15.75	12.25	0.00	1.75	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	194.42	26.77	7.90	25.46	17.99	0.88	3.07	3.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	82.23	22.04	2.54	12.72	5.09	0.85	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	117.59	27.46	4.18	14.92	6.57	1.19	4.18	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	129.56	19.90	5.82	9.22	9.70	0.97	2.91	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	44.51	0.00	5.71	1.14	2.28	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	27.03	6.24	0.42	4.57	4.16	0.83	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	13.49	7.87	0.00	3.37	1.12	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	53.92	4.44	26.96	6.98	5.07	2.22	0.32	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	74.78	5.43	169.19	5.43	5.85	6.27	2.51	3.34
Hep-2 cells mock treated, biol_rep1	11898-125E8	197.62	37.83	53.73	14.39	10.56	5.57	4.99	4.64
Hep-2 cells mock treated, biol_rep2	11899-125E9	215.05	29.71	64.48	11.98	10.13	4.39	5.06	5.06
Hep-2 cells mock treated, biol_rep3	11900-125F1	208.39	30.94	59.61	11.15	8.65	4.32	2.73	4.32
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	182.44	36.29	54.33	10.38	9.62	3.94	5.79	4.92
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	202.45	38.25	54.16	9.46	8.17	5.16	3.87	4.94
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	200.21	30.14	57.27	10.76	8.83	6.03	3.66	4.95
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	184.44	35.00	53.55	11.96	8.34	5.11	4.61	2.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	202.09	31.22	56.10	7.38	7.89	4.12	4.12	4.29
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	188.70	27.55	50.94	8.33	6.09	3.84	2.88	7.37
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	68.83	27.42	3.36	15.11	5.60	0.56	1.68	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	48.91	26.83	0.00	5.63	2.60	0.43	1.30	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	52.88	15.86	0.00	5.29	2.64	5.29	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	174.60	73.72	27.51	17.28	5.64	9.17	2.47	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	106.07	31.97	42.14	10.17	2.91	5.09	0.00	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	75.18	43.88	2.97	5.59	4.20	2.62	1.05	1.57
Hepatocyte, donor1	11523-119I2	49.63	16.95	315.97	6.05	0.00	44.79	2.42	7.26
Hepatocyte, donor2	11603-120I1	75.41	4.31	107.73	5.39	2.15	30.17	2.15	4.31
Hepatocyte, donor3	11684-122I1	35.59	15.95	346.65	8.59	0.00	24.54	1.84	5.52
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	43.73	36.55	0.00	1.96	1.96	0.00	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	165.69	47.19	12.23	23.95	6.47	2.45	1.92	3.67
Iris Pigment Epithelial Cells, donor1	11530-119I9	150.52	34.99	84.79	11.94	10.43	4.53	1.78	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	76.41	19.10	6.37	6.37	12.74	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	13.35	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	27.08	0.00	0.00	54.17	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	56.76	19.38	1.38	5.54	4.15	1.38	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	42.55	22.52	0.00	7.51	2.50	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	11.87	11.87	0.00	0.00	0.00	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	51.26	23.07	5.13	5.13	2.56	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	63.99	32.00	4.57	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	66.60	27.61	0.00	4.87	8.12	0.00	0.00	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	51.69	10.00	3.33	10.00	8.34	1.67	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	61.72	25.41	0.00	0.00	10.89	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	47.64	19.85	0.00	7.94	1.32	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	72.06	28.82	8.87	5.54	4.43	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	68.10	26.19	0.00	26.19	5.24	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	43.46	25.19	1.89	7.56	4.41	0.00	0.63	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	47.95	21.65	0.00	9.28	3.09	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	41.35	23.26	1.29	4.52	4.52	0.00	0.65	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	62.79	28.98	6.44	11.27	3.22	0.00	1.61	4.83
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	131.43	23.90	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	48.89	35.04	1.63	5.70	6.52	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	52.06	20.15	1.68	6.72	7.56	0.42	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	46.61	12.06	0.00	6.43	6.43	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	46.16	16.62	4.62	9.23	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	30.16	30.16	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	45.32	23.13	1.42	4.72	5.19	0.00	0.00	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	45.35	13.60	1.81	7.26	6.35	1.81	0.00	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	29.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	34.44	20.45	2.15	6.46	1.08	0.00	2.15	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	43.20	17.79	2.54	2.54	3.81	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	131.44	0.00	0.00	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	40.81	17.86	1.28	5.74	1.91	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	49.21	23.69	7.29	1.82	5.47	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	31.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	25.71	19.99	2.14	3.57	8.57	1.43	0.00	3.57
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	63.05	16.59	3.32	0.00	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	43.52	21.61	0.93	6.17	3.40	0.00	0.31	1.85
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	43.90	15.80	3.51	8.78	3.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	50.29	18.86	0.00	3.14	0.00	0.00	0.00	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	36.86	25.03	0.70	9.04	8.34	0.00	0.70	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	26.56	2.21	6.64	2.21	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	22.69	0.00	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	14.82	27.90	0.00	3.49	3.49	0.87	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	22.50	0.00	4.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	20.91	0.00	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	11.73	20.27	0.00	0.00	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	38.79	24.94	1.39	2.77	4.16	1.39	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	42.74	11.40	5.70	5.70	0.00	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	44.18	25.77	2.76	3.68	2.76	0.00	0.00	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	24.20	6.05	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	31.04	0.00	0.00	0.00	0.00	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	12.69	20.09	1.06	0.00	1.06	1.06	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	332.52	30.52	54.35	29.13	15.59	5.30	5.96	3.92
Keratinocyte - epidermal, donor2	11349-117G8	77.30	18.15	6.44	12.30	1.76	0.59	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	197.83	57.55	24.52	21.49	9.37	2.18	1.89	4.07
Keratinocyte - oral, donor1	11251-116E9	265.74	72.42	13.17	37.23	11.12	3.41	2.50	3.63
Keratocytes, donor1	11527-119I6	72.89	45.73	4.13	8.94	2.75	1.03	0.34	0.00
Keratocytes, donor2	11607-120I5	142.96	36.33	84.37	10.55	3.52	9.37	1.17	1.17
Keratocytes, donor3	11688-122I5	103.54	20.35	29.64	11.66	4.15	7.51	1.78	2.37
Krukenberg tumor cell line:HSKTC	10687-109F3	24.18	6.59	2.20	0.00	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	135.92	25.89	16.18	14.02	4.31	2.16	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	302.63	37.48	9.23	20.30	24.22	2.65	1.85	0.35
Lens Epithelial Cells, donor3	11690-122I7	163.17	33.60	22.81	13.62	10.80	7.87	1.82	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	17.91	9.60	1.66	4.51	0.71	0.71	0.36	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.65	5.58	0.84	1.40	1.40	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	8.03	6.77	2.68	2.68	0.94	0.79	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.60	6.45	2.15	2.15	1.08	1.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.03	5.99	0.95	4.41	1.26	0.00	0.63	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	4.64	5.18	2.16	1.19	0.65	0.65	0.00	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	14.77	5.75	3.28	3.69	0.82	1.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.58	4.05	1.26	2.53	0.76	1.01	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.30	5.91	1.69	1.97	0.84	1.55	0.28	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.47	5.54	1.98	1.58	1.58	0.79	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.89	7.95	1.55	3.10	0.97	0.78	0.00	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.48	4.44	1.67	1.48	0.37	0.56	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	16.03	3.14	2.79	3.48	0.35	0.70	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.73	7.87	1.43	4.05	0.95	0.95	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.73	4.81	1.51	2.47	0.55	0.82	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	12.63	3.08	1.54	0.62	0.00	0.31	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.48	4.36	0.62	2.18	0.62	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	7.50	6.95	1.83	2.74	0.55	2.01	0.18	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	13.49	4.61	2.63	1.65	0.66	1.65	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	10.25	4.10	1.76	4.10	0.88	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.22	4.48	1.74	1.24	0.75	0.50	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	13.09	5.82	3.88	0.97	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	7.00	4.58	0.54	2.96	1.08	0.00	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.87	6.81	2.12	1.51	1.06	1.21	0.15	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	14.52	4.15	4.15	2.59	1.56	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	9.84	3.14	0.63	2.93	1.68	0.63	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	8.27	5.56	1.65	3.61	1.20	1.95	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	13.07	4.82	3.44	2.06	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.72	5.64	1.13	4.14	2.07	0.75	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.86	5.51	2.12	2.54	1.17	1.17	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	11.15	4.36	2.91	1.94	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.28	3.97	0.66	3.64	1.32	0.66	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	10.16	7.31	2.85	2.60	0.50	1.49	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	19.99	5.18	2.22	5.18	0.74	1.85	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.17	5.44	0.49	3.21	0.49	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.74	6.60	2.61	2.61	0.96	0.96	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	15.76	8.68	3.22	3.54	0.32	0.96	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	9.13	5.78	0.61	2.43	1.52	0.30	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	10.50	7.84	2.10	2.94	0.28	0.84	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.44	3.56	2.84	3.91	0.36	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.79	5.33	1.45	1.94	0.48	1.45	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.38	5.60	1.71	2.02	0.31	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	16.47	5.37	5.01	1.43	0.36	2.15	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	10.45	7.84	1.31	3.27	1.31	0.98	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	7.53	4.00	0.71	0.94	0.47	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	18.44	9.78	3.09	2.35	1.49	1.98	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.22	4.61	1.79	3.33	0.00	1.02	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	7.76	2.98	5.07	3.28	0.30	0.90	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	92.91	9.06	9.06	11.33	9.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	104.33	23.78	12.27	4.60	0.77	1.53	2.30	3.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	84.61	17.07	23.75	5.20	2.23	0.74	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	96.47	19.89	13.96	8.46	3.39	4.23	2.54	2.96
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	81.59	16.88	17.58	10.55	6.33	0.70	0.00	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	86.86	20.55	18.68	6.54	3.74	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	82.44	10.82	9.27	5.15	3.61	1.03	3.09	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	76.13	13.08	13.08	5.95	1.19	0.00	3.57	4.76
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	76.91	16.74	5.43	5.43	2.94	1.58	0.68	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	118.95	19.78	8.43	8.14	6.40	2.62	3.78	2.91
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	107.14	20.71	15.31	5.40	2.70	1.35	3.15	3.15
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	115.43	21.68	7.18	10.70	6.50	2.17	1.76	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	101.68	13.35	8.73	7.19	2.05	2.05	3.08	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	103.39	19.05	21.52	4.23	4.59	1.41	0.71	2.82
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	110.61	15.99	10.66	2.00	3.33	1.33	0.67	3.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	102.39	21.39	8.15	6.11	5.09	2.55	2.04	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	118.46	24.55	21.88	7.47	5.87	1.33	2.40	3.47
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	119.60	21.92	7.56	8.88	4.91	2.83	1.13	3.02
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	80.38	13.50	6.14	1.84	5.52	1.23	3.07	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	110.08	28.54	23.65	9.79	5.71	1.63	4.89	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	118.28	25.20	8.33	8.33	6.04	1.67	2.29	3.54
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	121.07	19.62	17.10	7.57	4.20	1.12	2.24	5.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	105.09	22.67	24.73	6.18	5.15	1.03	0.00	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	104.22	22.93	6.39	8.42	4.06	1.74	2.90	4.35
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	107.32	20.03	13.45	5.08	5.98	0.60	3.89	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	120.61	21.58	16.60	7.19	6.09	2.77	1.11	4.98
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	114.18	22.98	5.30	9.19	7.07	1.77	2.12	3.18
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	91.09	17.70	8.48	7.01	4.06	2.21	0.74	6.27
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	79.44	14.97	17.27	8.06	2.30	1.15	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	98.62	16.89	8.83	4.22	4.22	0.77	1.15	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	89.45	16.42	9.62	7.93	4.53	0.57	4.53	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	109.12	25.43	25.43	6.56	1.64	0.82	1.64	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	91.73	21.24	6.33	5.87	4.97	1.36	2.71	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	99.10	13.64	7.18	6.46	7.18	0.00	2.87	4.31
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	118.76	29.88	18.67	5.98	1.49	1.49	1.49	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	106.28	20.44	9.66	6.69	5.95	3.72	3.72	4.83
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	95.63	15.08	9.05	8.18	3.88	2.58	1.72	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	112.17	29.97	24.83	7.71	5.14	0.86	1.71	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	111.28	18.66	10.66	8.66	5.66	0.33	1.67	4.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	94.12	21.72	11.46	4.22	2.41	0.60	4.22	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	71.81	18.49	14.93	4.98	1.42	0.71	1.42	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	96.24	26.81	4.81	7.56	6.87	2.06	2.41	3.44
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	100.37	19.86	8.59	5.90	5.37	1.07	2.68	3.22
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	84.17	19.53	20.20	7.41	6.73	0.67	3.37	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	102.60	20.37	8.89	12.22	3.70	1.85	3.33	4.82
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	100.01	13.96	5.81	6.98	3.49	2.33	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	62.41	20.10	12.69	4.23	0.00	0.00	2.12	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	88.03	20.81	8.00	3.20	5.20	2.40	2.00	3.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	65.42	18.17	6.54	6.54	1.45	0.73	2.18	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	68.22	13.80	16.10	9.20	5.37	2.30	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	94.71	22.20	7.89	6.41	3.45	2.96	2.96	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	61.16	16.94	6.59	3.76	4.70	0.94	0.94	3.76
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	80.45	20.62	20.62	5.53	2.01	2.51	0.50	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	89.67	11.27	7.66	8.56	4.96	3.15	0.90	6.31
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	74.01	12.05	5.16	5.16	5.16	0.00	0.00	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	95.30	18.26	14.70	5.79	5.79	2.23	2.23	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	84.46	15.25	5.47	7.04	5.08	0.78	3.13	6.65
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	89.06	20.45	8.58	1.98	3.30	1.32	3.30	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	89.77	25.95	19.20	6.75	1.56	1.04	1.56	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	95.39	19.69	10.06	8.75	6.13	3.06	3.06	9.19
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	79.95	21.25	8.39	5.03	3.91	0.56	0.56	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	87.45	22.08	6.18	6.62	5.30	3.09	1.77	3.97
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	100.29	17.74	8.87	7.71	5.01	2.31	1.16	3.86
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	89.62	14.68	8.61	7.09	2.03	2.03	3.04	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	102.85	20.67	18.26	5.29	3.84	2.40	1.44	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	98.19	16.70	8.35	6.36	2.39	1.19	1.99	3.18
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	107.55	19.44	17.01	4.86	4.86	3.04	3.04	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	120.36	13.14	12.45	6.92	4.84	0.69	4.84	4.15
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	102.22	19.76	8.74	8.36	4.56	2.28	3.42	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	121.87	12.91	9.30	4.65	6.20	3.10	3.10	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	119.12	16.33	21.16	9.07	4.23	0.60	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	105.53	20.60	12.36	7.92	4.12	2.54	2.85	3.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	85.29	18.13	27.72	4.80	2.13	1.07	0.00	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	120.11	9.19	21.26	6.90	5.75	2.30	2.87	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	107.47	15.43	12.86	8.74	3.09	3.60	3.60	7.20
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	100.44	20.51	16.98	7.07	2.12	2.12	2.83	7.07
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	114.63	13.62	18.16	10.78	4.54	0.00	2.84	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	110.66	22.47	7.07	6.66	3.74	2.91	2.91	5.82
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	104.14	21.14	15.66	6.26	4.70	0.78	2.35	3.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	123.18	20.88	16.28	10.86	2.09	2.09	2.92	2.51
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	96.64	17.19	10.22	6.97	5.58	2.32	0.93	7.43
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	91.66	15.39	9.37	7.36	3.35	0.67	3.35	3.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	142.75	12.83	19.25	12.30	5.88	2.14	1.60	4.81
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	94.56	18.99	10.10	4.45	4.04	2.42	4.04	4.85
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	86.27	15.60	6.42	7.34	1.84	1.84	1.84	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	136.92	12.45	11.56	7.11	4.45	2.67	2.67	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	120.24	26.21	7.41	7.98	6.84	1.71	2.85	5.13
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	97.40	16.10	12.27	3.07	3.83	0.77	1.53	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	165.79	25.72	30.64	10.94	6.02	1.64	1.64	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	100.23	21.38	8.46	4.45	2.67	2.23	1.34	7.13
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	105.54	27.56	18.20	8.06	6.76	2.60	2.08	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	138.59	17.90	20.56	5.97	3.32	3.98	3.98	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	143.42	31.18	10.39	14.55	2.08	6.24	4.16	6.24
Macrophage - monocyte derived, donor1	11232-116C8	31.68	18.23	0.23	6.61	2.96	0.46	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	36.88	20.92	0.18	3.49	2.57	1.28	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	60.95	32.38	2.75	10.36	4.06	0.52	0.52	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	73.28	11.68	4.25	4.78	1.59	1.59	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	234.67	23.61	12.04	10.77	6.81	1.58	3.17	2.06
Mallassez-derived cells, donor3	11930-125I4	167.90	28.63	8.48	11.95	7.64	1.53	2.64	0.42
Mammary Epithelial Cell, donor1	11273-116H4	65.47	21.62	5.98	7.97	3.39	1.49	0.20	0.50
Mammary Epithelial Cell, donor2	11350-117G9	88.89	29.82	5.21	6.66	4.34	1.45	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	100.02	18.71	3.99	9.98	6.24	0.50	0.50	2.00
Mast cell - stimulated, donor1	11487-119E2	277.95	69.15	54.91	70.51	20.34	4.75	5.42	3.39
Mast cell, donor1	11563-120D6	152.26	47.37	1.84	19.79	12.65	0.54	1.95	1.19
Mast cell, donor2	11565-120D8	2.97	4.16	0.30	2.08	1.19	0.59	0.00	0.00
Mast cell, donor3	11566-120D9	1.80	3.15	0.00	0.68	1.13	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	6.21	2.66	0.35	0.89	1.42	0.00	0.18	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	120.98	26.17	0.22	10.31	7.98	0.78	0.78	1.00
Mast cell, expanded and stimulated, donor8	11942-126A7	27.43	2.33	0.58	3.50	2.33	0.00	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	40.96	15.26	0.00	7.11	7.34	0.00	1.26	0.34
Mast cell, expanded, donor8	11941-126A6	1.34	1.17	0.17	0.50	0.00	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	19.80	11.44	3.08	7.26	1.59	2.09	0.20	0.10
Melanocyte - dark, donor2	11582-120F7	111.44	33.57	70.95	9.00	3.81	5.54	0.35	3.81
Melanocyte - dark, donor3	11663-122F7	642.77	49.69	25.06	28.18	13.84	8.77	15.29	1.16
Melanocyte - light, donor1	11274-116H5	449.46	36.67	15.51	28.21	11.52	4.94	5.88	2.59
Melanocyte - light, donor2	11351-117H1	414.26	35.49	17.74	14.33	15.70	6.14	10.24	3.41
Melanocyte - light, donor3	11423-118G1	97.13	14.74	103.20	7.81	5.20	1.73	1.73	4.34
Melanocyte, donor1 (MC+1)	12641-134G4	146.61	40.09	1.04	14.06	8.12	0.94	2.92	2.08
Melanocyte, donor2 (MC+2)	12739-135I3	312.51	30.12	17.75	16.94	9.95	5.38	2.69	2.42
Melanocyte, donor3 (MC+3)	12837-137B2	866.51	58.39	28.93	52.50	18.48	6.70	11.79	11.52
Meningeal Cells, donor1	11493-119E8	784.18	39.70	40.94	34.36	58.80	8.81	2.73	0.99
Meningeal Cells, donor2	11573-120E7	441.47	33.89	128.08	19.37	58.98	6.60	3.08	8.80
Meningeal Cells, donor3	11654-122E7	201.06	14.67	7.66	16.87	24.12	3.67	0.82	0.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	128.32	24.52	67.87	13.12	6.84	6.84	1.71	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	87.75	20.83	9.96	7.25	4.13	3.22	2.11	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	36.80	0.00	49.94	6.57	2.63	3.94	1.31	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	71.95	10.47	117.73	6.54	5.23	5.23	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	37.32	6.46	5.74	2.15	2.15	0.72	2.15	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	117.95	18.64	41.51	11.65	5.72	6.14	4.66	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	100.03	18.10	65.85	6.03	7.54	7.04	1.01	4.52
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	229.64	62.19	53.40	17.36	7.25	7.47	1.98	1.10
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	107.40	37.26	40.91	6.58	2.19	2.92	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	100.46	32.74	13.91	7.98	3.68	2.46	1.84	1.23
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	129.09	10.53	30.33	15.24	5.12	3.19	3.32	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	39.40	18.21	5.20	2.97	1.12	1.49	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	222.89	36.84	167.89	24.08	7.50	15.39	5.53	3.95
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	17.51	6.53	1.19	3.56	1.78	1.48	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	16.35	9.34	0.00	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	185.08	103.10	22.41	13.45	5.12	1.92	0.64	4.48
Mesenchymal stem cells - adipose, donor0	11217-116B2	30.84	6.03	10.28	5.32	2.13	2.13	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	147.92	37.21	312.10	15.01	4.69	11.26	4.38	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	19.59	24.67	1.45	0.73	2.18	0.73	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	5.57	6.63	1.06	0.27	0.53	0.53	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	5.00	6.51	0.00	1.50	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	6.50	9.32	0.29	1.23	0.51	0.14	0.14	0.43
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	537.43	89.12	31.06	25.66	6.75	22.96	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	322.87	59.84	81.02	19.95	10.84	10.10	2.96	8.13
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	99.53	28.27	8.24	8.54	2.94	2.06	1.18	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	110.63	58.77	41.48	0.00	6.91	10.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	207.66	40.60	31.92	13.95	5.58	2.48	2.17	4.65
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	76.96	23.65	5.60	8.30	3.73	1.04	0.83	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	136.65	44.00	30.11	11.58	2.32	6.95	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	167.68	47.30	48.80	14.52	6.26	7.26	2.25	5.51
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	96.35	30.26	13.03	5.59	5.59	3.26	0.47	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	155.73	38.93	38.93	19.47	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	168.87	41.86	28.04	14.02	5.28	6.30	1.63	4.27
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	73.65	24.95	9.11	7.13	4.75	1.98	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	76.96	17.10	111.17	0.00	8.55	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	188.49	24.78	26.55	7.08	4.42	1.77	0.88	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	56.61	21.28	9.12	4.94	2.66	0.76	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	109.22	42.11	56.58	10.53	0.00	3.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	151.32	27.59	17.83	10.82	6.15	3.40	2.12	1.91
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	67.22	18.42	7.37	5.52	2.76	3.68	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	182.41	39.34	31.30	16.69	6.26	3.58	1.79	3.28
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	68.74	26.83	18.44	5.03	6.71	3.35	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	101.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	134.23	27.60	11.29	11.04	3.76	2.76	0.50	2.26
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	63.69	24.96	7.13	7.37	2.61	2.14	0.48	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	72.98	22.67	38.15	4.98	1.11	5.53	0.00	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	140.45	30.39	12.20	8.75	3.45	3.45	1.38	3.68
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	67.31	30.08	6.52	5.05	2.31	1.47	1.26	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	150.83	37.50	15.90	11.21	6.73	4.08	2.04	2.65
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	132.80	32.18	10.30	7.29	4.08	3.00	1.07	1.93
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	90.69	27.56	13.34	6.89	3.56	2.89	0.67	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	30.96	41.27	0.00	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	131.85	28.47	24.53	8.54	4.82	2.63	1.31	2.41
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	81.11	30.42	11.66	4.06	6.59	3.55	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	91.13	26.51	26.51	4.97	0.00	4.97	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	154.92	35.33	34.52	10.06	3.26	5.16	1.90	1.63
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	77.05	21.17	14.12	6.76	3.53	2.06	1.18	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	92.68	30.53	40.34	0.00	4.36	10.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	93.23	23.55	15.38	2.88	1.44	1.92	0.48	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	65.24	18.41	7.20	2.80	3.60	1.20	0.80	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	98.73	21.94	83.64	2.74	5.48	6.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	104.62	25.53	8.01	5.01	6.01	1.50	0.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	138.62	18.35	85.62	6.12	4.08	8.15	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	105.98	19.71	16.20	6.13	1.75	3.94	2.19	2.19
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	56.29	18.76	22.07	2.21	1.10	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	105.66	26.90	29.46	5.76	5.12	6.40	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	113.79	29.25	13.88	5.95	2.48	2.98	1.49	2.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	52.19	18.09	9.74	2.09	0.00	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	114.91	33.15	75.14	11.05	0.00	8.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	124.44	31.79	13.68	5.81	4.79	2.05	0.68	3.08
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	66.52	20.57	24.51	3.06	0.88	1.31	0.44	1.31
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	125.35	55.39	61.79	12.43	5.33	4.97	0.00	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	139.43	30.02	30.02	6.73	3.37	2.52	0.84	1.96
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	54.86	20.78	31.17	3.33	2.91	2.08	0.42	2.49
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	135.20	35.55	87.41	8.16	6.99	6.99	0.58	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	137.86	30.77	19.91	9.65	6.33	4.22	2.41	3.02
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	85.15	24.21	12.94	3.76	3.76	2.50	0.00	3.34
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	151.60	72.19	115.50	7.22	0.00	0.00	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	188.41	42.48	45.25	6.46	5.54	2.77	5.54	6.46
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	88.21	27.32	13.66	6.83	6.83	2.28	1.14	2.28
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	169.27	65.22	85.26	14.09	9.53	4.42	1.66	5.53
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	170.52	35.24	17.10	13.73	8.03	3.11	1.55	4.41
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	96.09	32.17	12.87	8.58	4.29	2.14	0.43	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	134.66	42.56	94.64	8.89	5.72	5.72	0.00	1.91
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	191.89	42.44	23.75	12.54	6.14	4.27	1.87	3.20
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	79.92	25.74	9.88	6.88	5.99	1.50	1.50	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	113.43	46.76	15.82	12.01	4.94	1.84	0.42	3.53
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	149.38	28.35	13.06	11.15	3.50	1.91	1.59	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	69.21	28.75	18.35	7.08	2.87	1.55	0.88	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	147.13	45.88	31.09	8.34	5.31	4.93	0.38	3.41
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	155.12	32.67	16.48	10.23	5.97	1.70	1.42	1.99
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	56.04	22.61	7.13	5.90	2.70	1.97	1.23	1.23
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	88.63	43.66	24.11	5.87	3.26	5.87	0.00	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	128.49	44.10	19.70	7.35	4.41	1.47	0.59	2.06
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	67.47	28.54	13.84	8.94	3.17	2.59	1.44	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	209.78	72.95	19.78	19.37	15.25	2.47	0.82	2.47
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	129.24	37.52	23.52	8.64	5.36	1.49	0.30	1.49
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	86.64	18.83	0.00	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	98.02	21.39	3.56	7.13	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	135.70	61.11	6.24	14.46	6.57	1.31	1.64	5.91
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	83.10	16.83	1.05	7.36	4.21	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	276.96	35.98	7.12	12.65	11.07	1.38	2.37	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	125.73	27.94	8.38	1.86	2.79	3.73	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	123.55	36.43	8.26	7.89	5.26	1.88	1.50	2.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	168.06	34.89	17.58	11.72	4.79	2.66	0.53	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	55.08	17.08	0.57	5.66	1.58	0.23	0.23	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	96.51	33.89	1.47	8.10	2.21	0.74	2.95	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	153.17	41.41	6.23	12.46	7.33	0.73	2.56	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	82.45	31.11	4.67	12.44	7.78	3.11	0.00	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	24.58	4.81	0.53	2.67	2.67	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	85.01	23.18	3.86	15.46	3.86	0.00	3.86	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	175.73	36.36	12.12	13.13	5.05	1.01	3.03	4.04
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	42.16	12.65	0.00	4.22	1.69	0.00	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	2.72	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	1.27	1.27	0.64	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	5.67	1.62	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	1.51	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	0.00	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	3.26	9.79	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	4.75	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	39.86	6.68	4.52	3.45	2.80	1.08	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	109.75	8.88	22.99	6.27	6.79	3.66	1.05	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	71.42	14.02	100.79	9.34	6.67	6.67	0.00	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	90.57	10.85	65.53	5.43	4.17	7.51	0.42	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	82.14	11.60	32.51	4.94	7.42	3.23	0.76	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	65.43	22.34	14.36	7.98	1.60	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	51.68	8.16	140.75	1.36	3.40	4.76	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	23.89	3.68	5.51	3.68	5.51	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	82.45	7.95	250.28	4.19	8.79	13.81	3.35	4.60
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	98.09	9.07	57.18	6.04	6.97	4.42	0.23	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	178.35	18.11	339.95	8.92	16.48	19.73	3.78	3.24
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	159.78	16.40	35.32	15.14	12.61	12.19	1.05	1.26
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	11.13	89.08	22.27	11.13	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	72.47	7.45	135.51	4.47	5.46	4.47	1.99	3.47
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	109.08	5.68	327.78	5.95	6.23	9.74	1.62	1.89
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	129.66	9.75	263.18	7.71	13.15	12.92	3.85	3.85
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	112.68	11.92	508.85	7.19	7.19	22.37	1.80	4.08
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	140.15	18.23	102.25	12.21	11.66	11.48	2.37	2.92
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	61.00	7.96	100.25	5.83	2.65	9.02	1.06	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	52.83	6.60	114.06	4.20	1.20	9.60	1.80	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	128.97	7.88	163.76	13.78	6.89	8.20	1.64	3.94
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	120.83	6.67	403.31	5.85	7.97	13.50	3.42	4.55
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	262.28	24.52	314.14	19.05	14.29	22.75	2.82	4.06
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	49.23	7.03	59.07	0.00	2.11	6.33	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	52.87	9.19	95.16	5.52	5.06	5.52	0.92	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	48.84	6.75	39.85	3.21	4.18	5.14	0.96	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	162.10	7.59	418.35	16.55	5.86	8.28	6.55	5.86
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	197.22	15.17	126.42	15.17	17.70	15.17	10.11	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	242.39	26.73	261.99	13.81	14.48	20.50	1.11	2.23
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	37.68	8.47	55.46	2.54	3.39	6.35	0.85	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	61.24	7.60	115.83	4.75	4.75	6.88	0.24	1.90
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	51.51	16.31	42.92	2.15	7.30	4.29	0.43	3.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	81.25	0.00	18.06	0.00	9.03	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	137.62	18.66	193.60	11.00	10.33	12.66	1.00	2.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	222.73	29.31	50.95	13.53	12.62	11.72	0.45	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	66.66	6.75	89.68	5.16	5.16	3.57	0.79	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	49.22	11.14	52.93	2.79	5.57	2.79	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	93.46	10.97	134.70	7.57	6.81	6.81	1.51	2.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	57.68	14.99	29.00	1.96	4.89	2.61	0.98	1.96
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	33.56	10.89	27.89	5.67	3.49	3.92	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	185.44	31.21	63.32	9.50	7.69	5.43	1.36	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	122.59	20.28	211.66	11.46	9.70	7.94	4.41	6.17
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	74.46	11.30	119.01	8.64	3.32	5.98	3.99	2.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	61.01	8.43	57.05	4.96	3.47	2.48	1.98	3.47
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	84.22	14.16	92.26	4.21	4.98	8.04	1.15	2.30
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	18.45	13.01	6.96	3.63	1.81	0.91	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	188.98	22.77	47.52	13.26	9.50	7.96	1.77	2.21
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	115.88	10.16	246.67	5.42	7.45	7.45	6.78	4.07
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	51.10	5.11	51.10	35.77	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.93	7.32	1.22	0.61	1.22	1.83	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	99.14	13.22	144.46	5.04	8.18	9.13	1.57	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.59	13.62	1.82	0.91	1.82	0.61	0.61	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	53.80	18.20	73.58	7.91	3.96	3.16	1.58	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	162.11	15.87	233.53	20.41	2.27	9.07	2.27	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	35.41	0.00	55.64	5.06	0.00	0.00	0.00	5.06
Myoblast, donor1	11241-116D8	14.41	4.84	2.24	2.11	0.75	0.37	0.37	0.25
Myoblast, donor2	11322-117D8	28.19	13.43	6.14	3.64	4.60	2.11	0.58	0.77
Myoblast, donor3	11398-118D3	33.46	5.89	2.35	3.36	3.87	0.34	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	133.97	32.25	1.46	5.25	5.25	0.29	0.88	0.58
Natural Killer Cells, donor1	11230-116C6	3.69	1.23	0.00	0.31	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	3.92	2.11	0.00	0.00	0.30	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	1.84	1.47	0.00	0.55	0.18	0.00	0.00	0.00
Neural stem cells, donor1	11275-116H6	213.77	69.32	5.81	33.75	39.56	3.63	2.18	1.81
Neural stem cells, donor2	11352-117H2	148.27	107.84	11.55	19.26	13.48	1.93	5.78	0.00
Neurons, donor1	11494-119E9	42.10	56.89	4.55	10.24	1.14	0.00	0.00	1.14
Neurons, donor2	11574-120E8	25.76	44.47	10.35	5.28	4.62	0.88	0.22	0.88
Neurons, donor3	11655-122E8	32.89	50.97	13.15	6.58	4.11	4.93	3.29	1.64
Neutrophils, donor1	11233-116C9	0.93	1.86	0.00	0.00	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.61	0.61	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	35.26	12.70	3.80	6.53	3.32	1.31	0.59	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	92.47	7.81	47.54	14.98	10.09	2.93	0.98	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	89.05	9.02	35.30	9.43	6.22	2.21	1.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	15.97	7.71	1.24	1.93	1.10	1.65	0.00	0.28
Olfactory epithelial cells, donor2	11934-125I8	23.16	11.43	2.03	3.18	1.59	1.45	0.00	1.45
Olfactory epithelial cells, donor3	11935-125I9	14.42	6.24	0.45	2.27	1.02	0.79	0.00	0.34
Olfactory epithelial cells, donor4	11936-126A1	3.51	6.43	0.29	1.85	0.97	0.39	0.00	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	117.96	87.87	27.68	16.85	2.41	1.81	3.01	1.20
Osteoblast - differentiated, donor1	11276-116H7	15.74	5.10	1.06	3.19	0.64	0.43	0.43	0.21
Osteoblast - differentiated, donor2	11353-117H3	43.44	8.00	75.45	5.72	0.00	4.57	16.00	6.86
Osteoblast - differentiated, donor3	11425-118G3	37.86	4.34	146.49	9.31	3.10	6.83	1.24	1.24
Osteoblast, donor1	11277-116H8	94.59	32.05	13.09	10.55	5.86	6.64	0.98	0.59
Osteoblast, donor2	11354-117H4	50.57	23.88	2.11	2.81	0.00	0.70	0.70	0.70
Osteoblast, donor3	11426-118G4	50.48	20.26	7.64	4.62	3.73	2.31	0.71	0.36
Pancreatic stromal cells, donor1	11249-116E7	85.75	18.28	16.76	12.21	6.40	5.39	2.70	1.10
Pericytes, donor1	11491-119E6	250.68	6.45	28.93	8.46	18.69	3.45	3.23	0.89
Pericytes, donor2	11571-120E5	171.59	12.45	20.15	9.05	11.54	2.49	2.72	2.26
Pericytes, donor3	11652-122E5	130.41	57.98	37.84	8.54	5.70	5.49	1.02	3.87
Perineurial Cells, donor1	11499-119F5	221.52	21.02	51.54	13.56	24.98	5.99	2.03	0.79
Perineurial Cells, donor2	11579-120F4	145.93	54.65	31.10	11.69	6.99	8.37	2.02	1.29
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	0.64	0.96	0.00	0.00	0.00	0.00	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	1.71	0.98	0.00	0.49	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	2.46	1.42	0.00	0.39	0.26	0.00	0.00	0.13
Placental Epithelial Cells, donor1	11278-116H9	3.59	0.72	0.00	0.24	0.00	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	95.36	11.09	1.11	4.44	2.22	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	80.10	16.69	2.36	8.25	2.94	0.59	0.79	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	13.92	2.53	6.96	2.85	0.95	0.63	0.00	0.63
Preadipocyte - breast, donor1	11467-119B9	43.71	6.38	27.95	7.13	3.56	3.94	1.88	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	39.42	7.05	19.19	5.22	4.57	3.39	0.26	0.39
Preadipocyte - breast, donor2	11328-117E5	22.51	9.23	4.28	3.83	2.25	1.80	0.45	0.90
Preadipocyte - omental, donor1	11468-119C1	44.97	8.10	47.95	11.40	6.50	6.07	2.88	0.85
Preadipocyte - omental, donor2	11329-117E6	17.46	9.17	2.18	2.62	2.62	0.87	0.44	0.87
Preadipocyte - omental, donor3	11403-118D8	28.22	14.61	5.44	5.01	2.29	1.15	0.43	0.29
Preadipocyte - perirenal, donor1	11469-119C2	17.72	1.97	10.83	4.92	0.98	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	29.48	8.91	2.76	3.07	0.61	1.84	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	46.39	15.05	3.90	8.68	5.14	3.19	0.89	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	31.50	11.58	5.45	2.89	2.55	1.70	0.85	0.34
Preadipocyte - visceral, donor1	11280-116I2	32.60	8.66	4.38	7.17	2.89	2.42	0.65	0.19
Preadipocyte - visceral, donor2	11357-117H7	23.93	7.82	1.84	3.22	1.84	0.92	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	8.15	4.49	3.34	2.51	1.36	0.94	0.21	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	100.17	30.32	2.11	25.80	7.69	0.91	4.53	1.51
Prostate Epithelial Cells, donor2	11331-117E8	64.19	22.07	9.48	8.80	5.69	0.41	4.33	2.57
Prostate Epithelial Cells, donor3	11404-118D9	12.80	10.59	0.43	4.23	2.08	0.12	0.43	0.61
Prostate Stromal Cells, donor1	11254-116F3	26.31	19.02	4.21	4.56	2.39	1.82	0.46	0.23
Prostate Stromal Cells, donor2	11332-117E9	42.49	20.44	9.86	4.48	3.59	1.79	0.72	1.61
Prostate Stromal Cells, donor3	11405-118E1	34.10	19.19	7.51	5.32	3.13	3.02	1.77	1.15
Renal Cortical Epithelial Cells, donor1	11516-119H4	187.24	47.08	3.65	22.99	5.84	0.36	1.82	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	111.04	40.13	1.94	17.12	5.54	0.49	0.83	1.04
Renal Epithelial Cells, donor1	11517-119H5	101.95	44.64	1.01	7.10	4.06	0.00	0.51	1.52
Renal Epithelial Cells, donor2	11597-120H4	66.15	26.32	1.42	4.98	4.98	0.71	1.42	0.71
Renal Epithelial Cells, donor3	11678-122H4	66.27	29.75	0.95	11.01	4.02	0.53	0.74	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	41.53	19.74	0.68	4.77	2.04	1.36	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	51.48	28.44	3.50	6.87	3.23	0.81	0.54	1.21
Renal Glomerular Endothelial Cells, donor3	11675-122H1	32.41	21.76	1.11	4.22	2.89	1.11	0.44	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	16.64	10.65	0.67	2.66	0.00	0.00	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	159.78	61.62	6.38	10.34	4.62	2.86	0.44	0.66
Renal Mesangial Cells, donor2	11598-120H5	193.11	57.06	25.08	12.54	4.39	3.13	5.02	1.88
Renal Mesangial Cells, donor3	11679-122H5	92.10	34.68	8.32	7.49	3.33	2.50	1.39	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	157.30	64.15	1.61	16.11	6.98	0.54	1.07	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	87.71	46.39	6.75	12.23	4.64	0.84	0.84	5.48
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	113.59	57.85	0.77	16.01	8.49	1.16	0.77	1.54
Retinal Pigment Epithelial Cells, donor0	11215-116A9	167.50	85.30	41.23	14.78	5.19	4.15	2.59	2.07
Retinal Pigment Epithelial Cells, donor1	11528-119I7	134.73	58.84	8.24	17.91	4.55	3.13	2.84	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	147.16	57.63	41.16	9.26	3.09	3.09	2.06	3.09
Retinal Pigment Epithelial Cells, donor3	11689-122I6	25.09	18.32	2.26	9.03	3.26	1.51	1.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	22.32	13.50	157.42	4.54	2.14	19.51	4.01	1.87
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	26.80	9.83	0.00	5.36	2.68	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	27.52	10.46	0.00	4.40	7.71	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	39.44	13.92	1.16	2.90	2.32	1.16	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	168.25	29.91	0.65	16.90	14.69	0.91	0.13	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	113.41	26.91	1.09	12.71	14.50	0.40	0.40	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	113.66	24.43	0.33	12.60	13.27	0.89	0.22	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	74.43	18.98	0.12	10.30	12.65	0.12	0.37	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	89.51	26.81	0.82	10.72	11.65	0.70	1.17	1.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	94.76	32.82	0.23	11.56	9.71	0.23	1.16	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	122.26	26.42	0.55	15.74	10.13	0.55	0.68	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	81.84	22.69	0.61	8.77	11.19	0.91	0.91	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	86.19	24.91	0.00	11.83	9.32	0.36	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	111.61	22.38	0.72	12.77	9.18	0.29	0.29	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	83.06	25.86	0.21	10.09	10.30	0.64	1.18	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	66.38	26.11	0.66	7.97	7.52	0.00	1.11	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	163.84	27.15	0.38	15.68	10.71	0.38	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	88.13	28.69	0.28	10.62	9.88	0.19	0.84	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	134.35	21.42	0.56	12.97	13.91	0.38	0.94	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	152.88	29.86	0.40	17.78	15.26	0.66	0.00	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	90.53	32.12	0.49	11.88	9.44	0.68	0.58	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	95.86	29.41	1.72	11.65	12.41	0.00	0.57	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	133.28	25.10	0.85	16.02	15.38	0.43	0.53	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	99.51	33.36	0.84	10.37	10.65	0.84	2.52	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	104.59	25.29	0.34	9.23	12.48	0.17	0.51	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	148.42	22.79	0.36	18.60	8.39	0.91	0.36	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	96.63	29.68	1.10	11.90	12.26	0.74	0.49	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	101.55	29.68	0.67	11.55	11.95	0.67	0.54	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	170.30	21.23	0.00	14.62	9.91	0.47	0.71	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	108.53	36.11	0.60	10.91	15.67	1.39	1.19	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	122.54	35.31	0.94	10.29	11.93	1.87	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	141.00	22.60	1.04	15.97	11.61	0.21	0.41	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	111.27	32.96	1.33	13.94	13.94	2.21	0.44	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	118.02	31.12	0.84	11.49	12.53	1.25	1.04	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	151.00	25.03	0.54	16.15	12.92	0.81	0.54	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	119.38	32.87	1.02	13.45	11.58	1.02	0.17	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	119.53	34.32	1.93	13.69	11.76	1.35	1.54	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	102.99	19.60	0.52	13.58	4.64	0.17	0.69	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	76.40	25.10	0.69	8.23	9.19	1.37	0.27	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	70.43	23.31	0.49	8.04	7.39	0.82	0.82	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	149.98	26.08	1.19	17.72	10.06	0.68	0.34	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	95.58	26.19	1.18	12.43	9.03	0.59	0.15	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	105.02	24.79	0.27	10.66	9.33	0.53	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	57.66	21.71	0.55	12.03	8.57	0.00	0.41	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	80.00	24.52	2.14	6.67	10.00	0.24	0.48	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	131.81	43.53	1.21	13.30	12.90	0.81	0.40	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	86.73	18.55	0.38	14.22	8.38	0.00	1.04	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	25.15	15.37	0.00	5.94	5.59	0.00	1.05	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	38.38	16.32	0.30	7.25	5.44	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	135.11	22.40	0.49	19.83	13.83	0.73	1.35	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	27.95	16.01	0.00	7.13	4.08	0.00	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	17.04	9.73	0.00	4.87	4.26	0.00	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	132.92	16.28	0.30	16.88	9.64	0.30	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	19.68	16.74	0.23	5.65	3.85	0.23	1.36	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	23.06	16.77	0.30	5.69	3.29	0.00	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	32.47	12.16	0.00	13.46	5.79	0.24	2.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	27.53	12.59	0.00	8.11	4.70	0.21	4.27	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	25.84	12.62	0.60	3.61	3.00	0.00	0.60	1.20
Schwann Cells, donor1	11498-119F4	211.58	35.36	47.39	17.11	19.75	2.07	2.63	3.20
Schwann Cells, donor2	11578-120F3	112.28	6.80	0.00	10.21	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	214.92	28.26	20.16	7.23	12.49	5.70	1.97	1.75
Sebocyte, donor1	11220-116B5	213.08	73.95	19.17	35.61	13.15	2.74	1.64	2.19
Sebocyte, donor2	11301-117B5	170.49	44.12	15.17	19.76	10.11	4.60	4.60	9.65
Sebocyte, donor3	11378-118B1	123.87	17.11	34.83	10.72	7.01	2.89	2.68	3.30
Sertoli Cells, donor1	11255-116F4	4.97	4.97	4.97	6.63	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	5.65	2.82	0.00	2.82	5.65	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	7.57	5.10	0.00	3.08	1.06	0.44	0.09	0.00
Skeletal Muscle Cells, donor2	11358-117H8	41.20	4.34	20.24	6.51	2.89	0.72	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	5.02	6.69	0.84	2.51	0.84	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	106.67	14.77	157.25	11.78	7.70	11.15	2.67	4.40
Skeletal Muscle Cells, donor5	11455-119A6	149.24	16.95	249.72	16.50	8.47	11.00	3.72	4.01
Skeletal Muscle Cells, donor6	11459-119B1	117.12	28.47	32.01	14.01	7.23	2.00	0.77	2.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	304.05	24.07	148.44	38.31	11.72	12.73	7.56	5.67
Skeletal Muscle Satellite Cells, donor2	11321-117D7	202.48	22.97	160.67	21.69	10.56	11.70	6.42	9.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	128.48	28.27	27.88	13.69	10.32	7.14	2.68	3.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	67.99	18.03	5.31	9.27	5.56	2.78	2.36	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	4.34	3.62	0.00	1.45	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	71.41	8.39	146.54	4.95	4.82	8.53	2.20	2.75
Skin - palm, donor1	10286-104F7	5.37	5.37	8.06	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	85.48	31.43	13.26	5.62	3.32	0.43	1.87	1.59
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	172.58	17.99	16.36	3.27	3.27	0.00	0.82	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	100.75	32.98	24.67	6.88	3.76	0.65	1.17	2.73
Small Airway Epithelial Cells, donor1	11256-116F5	41.29	16.12	2.09	7.23	3.20	0.14	1.39	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	55.28	38.96	3.80	10.41	4.78	0.98	0.56	1.55
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	202.99	67.03	60.90	16.92	9.09	2.33	1.48	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	30.28	22.11	1.12	5.47	3.00	0.22	1.27	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	7.71	8.64	1.85	3.09	0.31	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	53.14	30.01	31.35	13.34	5.11	0.67	2.45	1.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.11	7.05	5.88	2.35	2.35	2.35	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	15.69	7.73	0.88	2.65	0.66	0.66	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	9.45	5.51	0.00	2.76	1.18	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.86	7.73	1.55	1.55	0.77	3.09	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	32.02	14.01	1.00	5.00	3.00	4.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	23.95	9.98	2.00	3.06	2.13	1.06	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	15.96	4.88	2.44	1.99	0.89	0.22	0.00	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.19	6.40	1.15	2.05	0.90	0.26	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	160.84	7.16	224.66	5.54	12.37	8.79	2.93	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	225.63	19.20	66.45	10.93	15.06	9.75	5.32	2.07
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	130.55	42.71	125.00	9.68	6.12	6.41	2.42	2.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	97.77	40.51	45.87	9.92	5.86	4.39	1.63	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	105.94	19.48	66.37	16.44	5.18	16.13	3.35	4.26
Smooth Muscle Cells - Carotid, donor1	11285-116I7	16.16	4.04	1.77	2.78	2.27	1.77	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.98	11.92	1.91	3.34	1.43	0.48	0.48	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	136.56	35.25	42.03	10.91	4.87	5.31	3.98	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	150.24	46.28	104.82	10.33	5.60	7.32	6.03	7.53
Smooth Muscle Cells - Colonic, donor3	11396-118D1	127.52	47.34	54.79	10.71	6.30	6.82	5.35	5.88
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	10.52	5.88	0.77	0.93	0.93	0.46	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	4.31	6.47	2.16	2.16	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.37	4.18	0.60	2.09	2.09	0.30	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	101.05	67.94	20.48	7.51	5.12	2.73	1.02	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	117.09	48.30	25.99	17.75	5.65	2.83	1.33	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	4.43	6.04	0.40	1.31	0.70	0.20	0.20	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	3.87	6.37	0.00	0.23	0.91	0.00	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.64	7.25	0.60	2.42	1.21	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	26.49	31.26	1.85	2.91	1.85	0.26	0.79	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	89.35	32.22	11.58	12.38	4.93	4.26	2.40	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	63.49	38.44	21.66	8.26	3.51	5.13	4.01	2.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	97.15	5.83	62.40	11.16	8.62	10.15	7.36	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	10.40	7.24	1.21	2.71	1.66	0.45	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.75	6.00	0.75	0.75	1.50	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	64.61	40.06	1.29	9.05	0.00	0.00	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	19.53	7.44	3.26	2.79	3.72	1.40	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	8.08	5.55	1.01	2.52	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	4.39	3.13	0.00	0.94	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	73.16	14.16	103.84	4.13	3.54	5.90	4.42	2.36
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	115.38	51.15	23.16	11.75	7.91	9.75	0.92	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	115.86	19.62	172.85	14.01	10.28	11.21	4.20	3.27
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	10.94	6.19	0.00	1.73	0.72	0.29	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	18.36	10.20	2.80	1.78	0.76	0.25	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	35.91	18.24	6.58	3.95	3.01	0.19	0.56	1.50
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	170.07	77.98	20.26	13.69	6.57	2.38	2.24	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	123.17	54.97	11.31	14.24	5.45	3.27	1.34	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	33.33	9.05	4.76	5.24	1.43	0.48	0.48	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.85	5.87	0.73	2.94	0.49	0.24	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	46.40	26.07	33.36	6.41	2.65	3.54	2.65	1.55
Smooth Muscle Cells - Uterine, donor3	11466-119B8	56.76	38.62	17.26	6.44	3.22	2.34	1.46	1.46
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	55.59	18.85	23.91	7.00	1.75	3.11	0.19	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	102.61	13.22	132.23	10.05	3.70	5.55	1.59	3.97
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	3.72	2.98	2.23	1.86	1.12	0.00	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	7.19	8.26	2.52	0.72	0.72	0.36	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	10.50	7.67	0.85	1.42	0.28	0.28	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	13.79	10.63	0.39	2.36	0.79	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	2.29	2.03	0.76	0.51	0.51	0.25	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	2.80	5.59	0.00	2.40	0.00	0.00	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	36.37	7.94	25.92	5.43	2.09	0.84	1.67	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	71.96	22.00	99.01	8.25	1.83	6.88	1.38	2.29
Synoviocyte, donor1	11291-117A4	3.70	1.68	0.00	0.34	0.67	0.17	0.00	0.00
Synoviocyte, donor2	11368-117I9	4.36	1.17	2.35	0.67	0.17	0.17	0.00	0.00
Synoviocyte, donor3	11440-118H9	1.12	0.45	0.22	0.45	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	202.61	117.20	21.44	14.29	5.72	2.14	0.71	2.50
Trabecular Meshwork Cells, donor2	11612-122A1	55.50	41.62	91.17	5.95	1.98	7.93	0.00	5.95
Trabecular Meshwork Cells, donor3	11693-123A1	105.59	65.30	32.88	11.81	5.56	3.24	1.62	4.40
Tracheal Epithelial Cells, donor1	11292-117A5	96.70	36.63	7.46	13.98	4.44	1.22	1.86	0.86
Tracheal Epithelial Cells, donor2	11369-118A1	64.17	19.71	9.28	5.03	2.32	0.77	0.39	1.93
Tracheal Epithelial Cells, donor3	11441-118I1	68.15	13.17	4.58	8.02	3.44	0.00	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	19.19	11.93	149.23	5.66	1.48	19.44	4.18	3.44
Urethra, donor2	10319-105A4	5.40	3.60	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	151.96	36.13	7.70	11.69	4.25	1.06	0.80	0.53
Urothelial Cells, donor2	11600-120H7	121.37	34.45	27.64	11.22	5.21	2.40	2.00	2.40
Urothelial Cells, donor3	11681-122H7	131.33	37.82	13.06	10.77	4.58	1.15	2.52	2.52
Urothelial cells, donor0	11216-116B1	147.11	48.81	19.61	20.51	5.57	1.11	2.67	1.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	1.78	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	0.00	0.00	0.00	1.43	0.00	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	0.00	0.00	0.00	0.68	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	0.34	0.34	0.00	0.34	0.34	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	0.58	0.00	0.00	0.00	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	1.04	1.04	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	0.00	0.91	0.00	0.91	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	264.49	43.92	29.61	12.34	15.17	6.04	3.45	2.22
Wilms' tumor cell line:HFWT	10597-108E3	190.97	31.68	10.56	11.44	10.56	6.16	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	131.28	51.67	1.96	15.08	14.80	0.84	1.12	0.28
achilles tendon, donor2	10292-104G4	24.80	2.07	14.47	2.07	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	133.60	18.87	0.76	16.06	8.92	0.76	0.76	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	80.10	15.09	0.00	22.29	14.16	0.46	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	82.86	43.80	0.12	13.89	8.07	0.36	0.47	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	107.76	57.14	4.63	10.88	13.61	0.54	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	75.89	35.98	0.00	13.21	7.31	0.00	1.12	2.25
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	11.21	7.40	0.00	4.86	1.90	0.00	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	222.12	35.12	1.09	19.87	13.34	1.36	2.45	2.45
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	49.35	26.88	0.00	7.05	6.61	0.00	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	153.54	30.63	1.23	17.97	15.93	0.00	0.41	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	99.02	15.14	2.33	12.04	10.48	0.00	0.39	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	48.02	20.98	0.00	10.30	6.07	0.55	0.55	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	66.31	19.50	0.00	7.80	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	33.46	4.42	0.00	2.79	4.88	0.00	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	130.23	17.61	0.26	12.17	7.25	0.26	0.78	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	80.66	15.20	0.58	14.03	9.94	0.29	1.17	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	230.06	23.70	6.04	12.55	8.83	0.93	0.93	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	266.08	46.88	1.23	21.80	12.75	0.41	3.29	3.29
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	83.18	21.18	3.07	9.82	8.29	0.00	0.31	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	30.72	7.68	0.00	7.68	6.83	0.00	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	43.37	8.80	0.30	9.40	6.07	0.30	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	28.64	10.59	0.00	6.98	4.33	0.00	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	75.95	34.52	0.45	12.70	8.46	0.22	0.89	1.78
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	164.44	32.69	2.67	5.00	9.34	0.67	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	234.13	83.62	1.86	9.29	9.29	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	105.84	28.63	1.51	4.52	7.91	1.13	1.51	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	85.92	26.17	0.00	12.21	8.29	1.31	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	39.36	26.24	1.87	0.00	3.75	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	162.97	115.39	602.41	23.31	16.25	25.90	3.53	4.24
adipose tissue, adult, pool1	10010-101C1	21.72	9.62	405.64	10.86	1.55	9.00	40.64	5.58
adipose, donor1	10184-103D4	75.06	19.35	0.59	29.91	11.73	0.00	4.69	2.35
adipose, donor2	10185-103D5	40.55	17.44	0.00	10.14	8.11	0.41	1.62	0.41
adipose, donor3	10186-103D6	69.71	19.60	0.54	13.07	13.07	0.00	2.45	0.54
adipose, donor4	10187-103D7	69.34	11.27	0.00	19.07	11.27	0.00	2.60	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	86.01	239.10	107.79	23.04	13.57	5.68	2.21	2.37
adrenal gland, adult, pool1	10081-102A9	58.20	21.83	178.25	7.28	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	17.08	22.55	0.00	4.94	2.00	0.13	0.27	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	94.68	18.58	154.00	10.72	11.43	26.08	2.14	2.86
amniotic membrane cells, donor1	12235-129G3	15.77	2.78	0.70	1.16	2.09	0.00	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	2.03	1.35	0.00	1.35	0.68	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	6.48	1.18	0.00	0.88	1.18	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	61.66	85.38	34.39	10.67	1.19	1.19	0.00	7.11
amygdala, adult, donor10252	10151-102I7	57.59	124.90	24.53	13.79	6.29	2.43	3.45	7.71
amygdala, newborn, donor10223	10360-105E9	32.28	23.56	39.38	4.20	4.84	0.65	0.32	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	2.04	3.57	0.38	0.76	0.38	0.00	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	55.16	26.70	0.44	8.60	12.13	0.44	0.44	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	9.69	45.43	0.67	4.01	2.00	0.00	1.00	0.67
aorta, adult, pool1	10052-101G7	4.90	4.90	126.90	0.39	0.39	0.00	0.98	1.18
appendix, adult	10189-103D9	5.82	4.66	154.08	1.55	0.78	1.16	1.55	4.66
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	40.93	18.57	0.69	8.25	4.82	1.03	0.69	0.00
artery, adult	10190-103E1	6.79	10.87	27.17	1.36	0.00	0.00	2.72	1.36
astrocytoma cell line:TM-31	10425-106D2	80.98	43.17	0.14	14.63	6.23	0.14	0.87	0.87
b cell line:RPMI1788	10427-106D4	82.83	30.93	1.34	19.93	9.67	0.30	0.89	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	4.99	6.10	0.28	0.55	0.28	0.28	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	84.55	58.55	2.28	14.49	6.45	0.79	0.79	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	107.62	32.30	3.85	14.39	8.03	2.34	1.00	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	32.44	17.34	0.00	2.80	3.91	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	9.23	11.19	12.17	2.61	1.30	1.30	0.54	0.65
blood, adult, pool1	10053-101G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	2.57	0.86	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	10.80	6.07	231.47	3.37	0.00	0.00	2.02	3.37
brain, adult, donor1	10084-102B3	153.76	106.61	210.14	28.70	11.28	5.13	8.20	15.38
brain, adult, pool1	10012-101C3	106.79	116.59	7.91	26.95	10.02	2.56	9.35	5.57
brain, fetal, pool1	10085-102B4	34.73	74.80	13.36	5.34	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	34.69	9.58	0.99	4.63	2.64	0.33	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	675.67	87.63	134.18	40.69	24.84	19.22	3.25	3.00
breast, adult, donor1	10080-102A8	16.42	6.31	751.31	6.31	2.53	7.58	8.21	3.79
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	67.46	25.28	3.30	12.32	13.97	1.02	1.40	1.52
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	101.73	35.56	16.70	9.90	12.37	0.62	0.62	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	95.08	65.84	2.30	17.04	11.28	1.15	1.38	2.30
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	162.92	17.91	11.62	17.43	15.25	1.45	1.45	1.69
carcinoid cell line:NCI-H1770	10703-109H1	40.90	24.45	2.82	12.69	4.70	0.94	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	49.55	34.02	2.41	8.86	4.05	0.66	0.77	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	51.34	40.56	6.97	6.65	6.97	0.63	0.63	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	74.26	31.68	4.53	14.11	6.65	2.66	0.80	0.53
caudate nucleus - adult, donor10196	10177-103C6	95.56	89.80	34.54	10.36	3.45	2.30	1.15	3.45
caudate nucleus, adult, donor10252	10164-103B2	19.08	53.04	3.18	5.02	1.17	1.51	0.67	1.84
caudate nucleus, adult, donor10258	10379-105H1	30.57	37.44	12.99	6.11	0.76	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	18.68	19.41	5.86	3.66	1.83	2.93	0.73	1.83
cerebellum - adult, donor10196	10173-103C2	160.23	96.14	104.88	14.57	17.48	8.74	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	56.79	74.94	10.68	12.38	10.46	2.14	3.84	3.84
cerebellum, adult, pool1	10083-102B2	78.65	44.15	52.78	11.73	6.21	3.10	3.45	2.07
cerebellum, newborn, donor10223	10357-105E6	63.10	39.02	14.95	13.28	8.30	2.49	1.66	2.49
cerebral meninges, adult	10188-103D8	39.84	51.69	21.94	9.08	4.54	1.76	1.51	2.52
cerebrospinal fluid, donor2	10294-104G6	43.12	28.50	17.54	4.39	5.85	3.65	1.46	4.39
cervical cancer cell line:D98-AH2	10552-107I3	38.97	14.09	0.43	12.37	7.33	0.43	0.14	0.14
cervical cancer cell line:ME-180	10553-107I4	77.06	32.65	0.83	8.29	4.14	0.50	0.33	0.17
cervix, adult, pool1	10013-101C4	14.59	7.03	0.63	3.67	1.15	0.10	0.31	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	22.99	19.51	1.81	4.32	1.25	0.56	0.56	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	201.16	19.59	52.25	15.68	11.76	13.06	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	45.36	24.11	0.37	23.36	9.07	0.00	2.24	0.37
choriocarcinoma cell line:SCH	10785-110H2	259.24	84.28	16.26	47.19	17.37	2.34	4.31	2.71
choriocarcinoma cell line:T3M-3	10618-108G6	32.26	33.68	0.47	16.37	6.64	0.24	0.24	0.47
chorionic membrane cells, donor1	12238-129G6	35.90	9.12	5.41	2.56	1.99	0.28	0.85	0.28
chorionic membrane cells, donor2	12239-129G7	22.17	8.95	1.69	4.18	2.19	0.20	0.50	0.20
chorionic membrane cells, donor3	12240-129G8	45.61	6.59	0.55	4.95	4.40	0.00	1.65	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	35.34	16.16	0.00	3.03	2.02	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	61.28	13.64	0.77	7.30	5.19	0.77	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	88.70	24.71	7.81	7.39	7.60	1.27	1.27	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	140.98	45.97	3.85	15.15	11.81	0.51	0.51	3.85
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	178.99	59.74	4.84	12.82	14.27	1.94	0.48	3.87
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	171.85	53.75	3.46	17.31	12.01	1.83	1.22	4.68
chronic myelogenous leukemia cell line:K562	10454-106G4	88.93	24.44	0.00	14.43	12.07	0.59	0.88	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	53.95	35.97	2.09	5.73	2.09	0.78	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	20.12	32.00	0.69	8.69	5.94	0.23	1.83	0.91
clear cell carcinoma cell line:TEN	10636-108I6	27.24	21.69	0.00	6.07	2.43	0.17	0.52	0.17
colon carcinoma cell line:CACO-2	10513-107D9	146.07	62.23	0.18	23.98	10.07	1.10	1.28	0.55
colon carcinoma cell line:COLO-320	10420-106C6	25.85	65.75	0.76	14.82	3.80	0.38	0.38	0.76
colon, adult, donor1	10082-102B1	4.76	8.33	126.14	0.00	1.19	2.38	0.00	0.00
colon, adult, pool1	10014-101C5	7.87	3.88	117.86	1.76	0.47	2.82	7.52	1.06
colon, fetal, donor1	10070-101I7	6.80	0.62	21.63	1.24	0.00	1.24	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	27.50	18.33	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	105.81	23.37	2.55	15.30	7.65	1.70	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	135.23	16.15	2.87	18.72	14.49	0.75	1.21	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	165.69	19.18	4.79	16.08	13.96	1.41	0.99	0.56
corpus callosum, adult, pool1	10042-101F6	446.67	401.34	32.39	73.52	21.12	9.51	11.50	6.85
cruciate ligament, donor2	10295-104G7	11.35	3.24	249.62	3.24	0.00	4.05	0.81	3.24
diaphragm, fetal, donor1	10069-101I6	2.41	1.61	162.92	0.00	0.00	1.61	0.80	0.80
diencephalon, adult	10193-103E4	141.59	117.59	31.20	22.08	9.60	3.12	4.56	5.04
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	87.71	23.42	0.23	17.45	10.56	0.69	1.84	3.67
ductal cell carcinoma cell line:KLM-1	10438-106E6	134.63	34.36	2.82	16.93	16.67	0.26	0.51	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	307.40	58.98	126.14	18.78	14.92	24.31	19.02	4.09
ductus deferens, adult	10196-103E7	1.99	3.49	3.49	1.99	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	5.76	7.20	2.88	1.44	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	12.51	3.68	1.47	2.21	0.00	0.74	0.00	1.47
dura mater, adult, donor1	10041-101F5	5.95	8.84	0.41	1.90	1.32	0.33	0.08	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	14.66	9.10	0.67	5.11	4.22	0.00	1.55	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	107.33	18.91	1.72	11.75	11.46	0.43	1.86	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	25.90	9.25	3.08	5.55	6.17	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	48.13	26.03	6.96	6.66	4.54	1.21	1.21	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	29.33	12.04	6.17	7.41	5.56	1.23	0.00	0.62
embryonic pancreas cell line:2C6	10603-108E9	28.90	15.76	5.25	10.51	3.94	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	15.08	13.74	0.34	5.36	3.02	0.00	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	29.90	59.63	2.36	8.34	5.26	1.63	0.36	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	62.72	27.34	2.09	4.99	7.72	0.32	0.80	1.29
epidermoid carcinoma cell line:A431	10426-106D3	219.87	84.93	15.23	24.57	11.78	2.11	1.56	0.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	127.91	63.13	1.43	18.37	13.53	1.10	0.33	0.33
epididymis, adult	10197-103E8	3.98	2.93	10.26	3.14	0.42	0.42	1.05	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	296.45	88.00	169.96	14.55	13.48	24.31	11.18	3.73
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	226.51	19.66	123.08	11.40	15.73	13.37	4.33	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	171.02	61.59	9.44	22.15	17.17	3.67	1.97	5.11
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	179.03	79.03	8.66	26.18	21.46	2.66	1.18	4.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	158.19	62.74	10.19	19.94	13.89	2.58	1.79	4.59
esophagus, adult, pool1	10015-101C6	88.98	22.51	7.64	12.32	5.10	0.53	1.06	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	151.29	47.97	240.83	10.65	18.28	16.78	15.40	4.63
eye - muscle inferior rectus, donor1	10272-104E2	2.41	12.07	4.83	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	0.00	2.10	14.73	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	7.44	0.00	11.91	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	14.90	3.44	13.76	1.15	1.15	0.00	0.00	2.29
eye - vitreous humor, donor1	10268-104D7	14.57	1.46	8.74	1.46	0.00	4.37	0.00	0.00
eye, fetal, donor1	10054-101G9	6.61	10.68	63.81	2.03	1.53	0.25	0.51	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	66.04	42.06	7.44	7.69	6.41	1.15	0.77	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	12.82	14.48	0.00	5.94	2.85	0.47	0.00	0.71
frontal lobe, adult, pool1	10040-101F4	114.18	115.40	11.73	18.30	10.88	2.91	1.41	1.31
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	192.76	27.02	10.21	15.61	11.11	3.90	0.60	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	569.56	67.02	61.81	37.58	29.81	10.15	2.47	2.38
gall bladder, adult	10198-103E9	10.86	6.04	176.00	1.69	1.45	2.41	5.79	2.66
gamma delta positive T cells, donor1	11937-126A2	5.91	2.15	0.00	2.15	0.54	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	3.73	1.12	0.00	0.00	0.75	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	34.22	10.77	1.27	2.32	2.75	1.06	1.48	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	136.74	33.85	12.57	11.60	10.25	4.06	1.35	1.35
gastric cancer cell line:AZ521	10549-107H9	187.56	105.42	86.57	25.90	16.07	12.13	8.20	1.97
gastric cancer cell line:GSS	10560-108A2	146.44	44.85	13.73	19.22	30.20	0.00	3.66	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	77.90	18.96	1.60	13.94	5.48	0.69	0.91	2.28
giant cell carcinoma cell line:LU65	10487-107B1	22.37	20.19	0.11	4.82	2.87	0.00	0.34	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	186.15	64.94	13.86	19.59	10.78	3.22	1.96	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	95.53	37.66	1.50	16.96	13.72	1.00	0.50	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	420.84	71.46	24.28	20.90	24.70	8.55	2.01	1.06
glioblastoma cell line:A172, tech_rep2	10444-106F3	482.41	83.42	34.69	18.40	32.30	12.08	1.83	0.98
glioblastoma cell line:T98G	10485-107A8	245.25	30.35	25.39	10.93	15.56	7.17	1.77	0.88
glioma cell line:GI-1	10413-106B8	290.53	24.02	129.74	19.04	19.92	17.28	7.03	2.34
globus pallidus - adult, donor10196	10175-103C4	243.46	140.68	56.86	14.58	5.83	2.92	3.64	5.83
globus pallidus, adult, donor10252	10161-103A8	187.22	249.22	16.60	39.79	9.76	4.39	10.74	9.76
globus pallidus, adult, donor10258	10367-105F7	193.06	125.97	109.54	19.17	15.06	1.37	6.85	9.58
globus pallidus, newborn, donor10223	10364-105F4	112.45	60.22	25.58	14.92	6.40	4.26	4.80	2.66
granulocyte macrophage progenitor, donor1	12131-128D7	4.89	4.89	0.00	2.45	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	26.88	19.20	0.32	4.80	1.92	0.96	0.64	1.28
hIPS +CCl2, biol_rep1	14383-156B9	103.30	28.01	0.46	17.91	10.56	0.00	0.00	0.92
hIPS +CCl2, biol_rep2	14384-156C1	110.20	32.47	0.46	7.32	7.32	1.37	0.00	1.37
hIPS +CCl2, biol_rep3	14385-156C2	127.53	27.70	2.58	7.09	9.66	0.00	0.00	1.93
hIPS, biol_rep1	14380-156B6	129.36	15.81	0.00	1.44	2.87	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	91.91	15.09	0.00	2.06	4.80	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	142.35	71.73	8.83	12.14	1.10	1.10	1.10	2.21
hairy cell leukemia cell line:Mo	10712-109I1	22.41	16.09	0.86	2.30	2.01	0.29	0.00	0.00
heart - mitral valve, adult	10205-103F7	6.28	6.28	117.20	2.69	0.60	1.20	0.00	2.39
heart - pulmonic valve, adult	10206-103F8	3.14	2.09	51.25	1.57	0.52	1.31	1.05	0.52
heart - tricuspid valve, adult	10207-103F9	1.67	3.33	3.33	3.33	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	100.80	21.63	49.18	12.65	6.94	1.22	0.82	3.88
heart, adult, diseased, donor1	10051-101G6	0.00	3.41	12.77	0.00	0.00	0.43	0.85	0.00
heart, adult, pool1	10016-101C7	2.07	1.61	8.05	1.15	0.69	0.46	0.23	0.23
heart, fetal, pool1	10046-101G1	2.77	7.08	2.05	1.13	0.31	0.10	0.10	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	26.84	21.29	13.88	3.70	3.09	0.93	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	214.05	85.62	1.19	27.35	9.51	4.76	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	229.39	77.57	57.13	23.09	6.41	26.63	3.87	9.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	217.75	77.56	45.76	21.85	7.40	19.42	4.37	11.29
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	252.43	88.42	53.15	21.73	8.89	27.08	3.44	9.80
hepatoma cell line:Li-7	10484-107A7	420.51	48.60	20.57	25.02	23.91	17.91	2.56	2.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	96.88	48.64	2.61	13.67	7.24	0.50	0.70	0.50
hippocampus - adult, donor10196	10169-103B7	110.72	97.47	150.47	14.19	10.41	5.68	2.84	3.79
hippocampus, adult, donor10252	10153-102I9	97.36	183.49	23.88	19.59	9.18	6.33	5.31	9.80
hippocampus, adult, donor10258	10374-105G5	100.59	38.34	18.42	1.49	1.00	0.00	1.00	2.49
hippocampus, newborn, donor10223	10363-105F3	36.31	23.62	32.08	5.99	5.29	3.17	0.70	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	190.43	36.01	1.22	39.67	31.13	1.22	3.66	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	116.83	34.17	0.59	30.83	30.63	0.20	1.37	2.16
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	169.60	31.74	0.25	38.34	32.75	1.27	3.05	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	41.16	24.25	0.56	14.66	9.59	0.56	0.56	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	34.34	28.40	0.26	20.14	11.36	1.29	1.81	2.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	44.41	22.02	0.00	14.05	13.29	0.00	1.52	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	110.94	24.82	0.88	21.90	14.60	0.88	4.09	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	69.37	28.01	0.22	18.53	16.37	1.08	4.74	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	142.22	22.52	1.67	20.44	17.10	0.42	2.09	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	234.42	26.05	1.42	27.70	26.76	0.71	3.08	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	221.47	33.75	3.05	28.29	25.07	1.61	5.79	2.41
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	214.78	24.91	4.04	24.91	27.61	2.69	2.02	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	115.49	36.30	0.31	34.27	26.60	0.78	1.56	2.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	127.74	33.41	4.91	14.74	24.56	0.00	4.91	5.40
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	176.30	15.71	0.00	34.04	32.29	0.00	3.49	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	53.07	21.57	0.38	15.85	14.51	0.38	1.15	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	70.21	23.55	0.00	17.44	12.21	0.44	0.87	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	88.96	15.99	1.50	22.99	17.49	0.50	3.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	51.62	25.62	0.00	11.87	9.80	0.75	1.88	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	55.02	18.19	0.45	11.82	8.18	0.00	1.36	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	52.62	19.11	0.31	8.14	8.46	0.31	1.25	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	50.30	19.92	0.82	6.53	8.49	0.16	0.98	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	45.87	18.87	0.87	6.39	8.42	0.58	1.45	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	67.56	19.73	2.99	7.77	10.16	0.30	1.49	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	111.77	29.37	0.00	25.13	21.25	1.11	1.48	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	109.26	34.23	0.57	20.83	21.11	0.57	2.28	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	163.73	38.38	1.22	34.71	31.03	0.82	1.63	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	54.92	25.35	0.70	11.27	10.21	0.00	2.46	2.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	39.91	17.42	0.32	13.94	8.24	0.00	0.95	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	50.84	14.53	0.61	13.92	9.38	0.00	1.82	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	59.99	25.34	0.52	10.86	6.72	0.00	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	62.43	17.27	0.00	3.98	11.95	0.00	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	81.32	14.88	1.28	11.29	9.75	0.77	2.57	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	103.79	20.96	1.79	12.78	16.11	0.77	2.81	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	111.31	14.39	0.76	9.09	10.60	0.76	2.27	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	148.87	18.48	2.02	10.75	14.11	0.67	1.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	109.64	37.92	0.24	25.36	21.25	0.24	1.21	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	143.50	22.28	0.89	36.10	24.96	0.89	3.12	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	129.27	32.68	1.95	26.34	35.12	0.49	3.90	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	45.84	27.81	0.31	15.89	14.36	0.31	2.44	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	78.08	3.25	6.51	35.79	13.01	0.00	19.52	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	52.95	20.85	0.66	20.19	10.59	0.33	2.32	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	59.66	34.48	0.55	17.51	6.02	0.00	1.64	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	72.01	18.46	1.45	11.94	7.96	0.36	3.26	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	52.67	17.79	0.36	11.74	9.25	0.00	0.71	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	142.01	25.06	0.00	19.09	15.51	1.19	3.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	169.42	34.80	0.68	26.81	26.81	0.41	4.88	0.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	163.25	26.13	9.70	13.74	15.09	0.81	2.16	0.81
immature langerhans cells, donor1	11904-125F5	0.48	0.24	0.00	0.24	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	1.58	1.58	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	118.67	125.58	18.74	17.79	10.60	4.73	2.37	1.14
keratoacanthoma cell line:HKA-1	10791-110H8	113.15	13.66	3.25	7.48	7.48	0.33	0.33	0.65
kidney, adult, pool1	10017-101C8	3.60	2.60	0.90	0.10	0.40	0.40	0.30	0.10
kidney, fetal, pool1	10045-101F9	7.43	8.63	5.66	1.20	0.42	0.57	0.00	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	89.62	51.27	0.00	15.91	9.37	0.43	0.28	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	90.27	21.29	2.35	10.78	10.92	1.38	1.11	1.11
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	128.82	53.21	11.19	16.70	7.71	2.20	0.00	0.55
left atrium, adult, donor1	10079-102A7	6.54	4.36	1158.90	2.18	0.54	3.27	4.90	9.81
left ventricle, adult, donor1	10078-102A6	0.51	1.52	16.69	0.00	1.01	0.51	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	33.38	41.04	30.10	4.92	3.01	7.11	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	12.93	14.01	19.76	3.59	0.36	1.80	2.16	1.08
leiomyoma cell line:15242A	10570-108B3	11.41	5.43	8.15	0.00	1.63	0.00	1.09	1.09
leiomyoma cell line:15425	10571-108B4	9.96	9.47	6.31	1.94	1.21	0.49	0.73	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	54.37	48.10	1.05	7.32	3.14	1.05	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	21.60	20.90	0.59	3.19	1.53	0.24	0.35	0.00
liposarcoma cell line:KMLS-1	10782-110G8	151.06	15.46	19.53	6.09	10.62	2.03	1.09	1.25
liposarcoma cell line:SW 872	10726-110A6	76.03	27.41	31.68	6.94	4.75	4.87	0.97	0.61
liver, adult, pool1	10018-101C9	15.40	8.59	46.51	6.32	0.49	18.96	3.57	1.62
liver, fetal, pool1	10086-102B5	68.67	13.17	695.19	3.76	0.94	17.87	4.70	10.35
locus coeruleus - adult, donor10196	10182-103D2	203.72	187.97	25.23	32.23	11.67	8.60	8.90	9.77
locus coeruleus, adult, donor10252	10165-103B3	138.78	154.10	13.47	26.39	8.30	3.51	5.72	7.94
locus coeruleus, adult, donor10258	10375-105G6	165.33	117.65	88.59	19.47	8.46	7.34	12.70	9.59
locus coeruleus, newborn, donor10223	10362-105F2	76.13	60.57	46.27	21.87	11.78	6.73	7.99	4.21
lung adenocarcinoma cell line:A549	10499-107C4	224.20	48.02	17.85	31.42	18.82	6.23	2.77	1.25
lung adenocarcinoma cell line:PC-14	10408-106B3	102.03	24.13	2.07	8.96	9.65	2.07	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	134.72	47.19	25.57	13.84	10.28	1.45	1.19	1.32
lung, adult, pool1	10019-101D1	62.84	34.26	8.27	17.25	4.02	3.54	1.30	0.95
lung, fetal, donor1	10068-101I5	16.84	9.42	0.57	2.28	0.86	0.57	0.86	0.29
lung, right lower lobe, adult, donor1	10075-102A3	40.32	22.91	29.33	9.16	3.21	3.21	1.37	2.29
lymph node, adult, donor1	10077-102A5	11.36	6.63	179.40	1.89	2.37	1.89	1.89	0.95
lymphangiectasia cell line:DS-1	10727-110A7	64.22	33.75	3.29	10.30	6.36	1.10	1.53	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	123.31	25.51	0.00	17.05	8.90	0.30	0.91	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	114.68	28.88	2.55	11.04	6.80	0.00	1.70	0.85
mature adipocyte, donor1	12231-129F8	27.08	7.99	1200.99	7.99	4.44	24.42	13.32	10.21
mature adipocyte, donor2	12232-129F9	32.79	9.75	1054.04	11.83	3.53	20.34	18.26	9.55
mature adipocyte, donor3	12233-129G1	37.69	12.09	2724.33	21.34	4.98	37.46	60.45	25.13
mature adipocyte, donor4	12234-129G2	45.54	9.74	3241.78	18.69	4.74	34.74	45.27	32.64
maxillary sinus tumor cell line:HSQ-89	10414-106B9	98.16	60.52	2.38	31.69	22.40	1.67	1.19	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	85.73	45.12	60.91	9.02	4.51	2.26	2.26	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	70.25	97.29	7.54	13.98	5.89	1.47	2.94	4.78
medial frontal gyrus, adult, donor10258	10368-105F8	101.34	63.22	32.72	9.21	6.04	5.72	1.91	1.91
medial frontal gyrus, newborn, donor10223	10352-105E1	27.72	17.91	14.07	7.68	3.84	0.43	0.85	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	77.79	81.17	12.83	15.69	7.43	9.28	4.89	12.32
medial temporal gyrus, adult, donor10252	10156-103A3	96.14	136.46	12.52	15.70	6.79	3.82	3.61	5.73
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	61.64	23.12	7.71	3.85	1.93	1.93	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	86.12	14.35	28.71	14.35	0.00	14.35	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	25.13	16.51	6.82	3.59	1.79	1.44	0.00	0.72
medulla oblongata - adult, donor10196	10174-103C3	223.25	99.29	72.04	14.28	9.09	5.84	5.19	13.63
medulla oblongata, adult, donor10252	10155-103A2	154.18	167.50	14.86	32.04	11.46	4.33	11.77	9.44
medulla oblongata, adult, pool1	10038-101F2	256.80	239.49	21.30	40.32	13.14	6.37	5.63	3.43
medulla oblongata, newborn, donor10223	10361-105F1	96.52	69.09	51.38	18.05	9.03	3.47	3.47	2.78
medulloblastoma cell line:D283 Med	10838-111E1	8.86	13.73	0.44	6.64	2.88	0.22	0.44	0.66
medulloblastoma cell line:ONS-76	10759-110E3	60.65	54.29	3.06	6.48	4.77	1.47	0.73	0.86
melanoma cell line:COLO 679	10514-107E1	437.56	67.99	17.25	37.37	19.55	7.33	29.04	2.59
melanoma cell line:G-361	10465-106H6	148.49	17.92	3.26	13.03	8.42	1.63	2.44	0.27
meningioma cell line:HKBMM	10691-109F7	8.86	9.23	0.18	0.54	0.90	0.00	0.00	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	125.12	33.48	3.52	25.55	8.81	0.00	2.64	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	18.92	6.74	0.00	3.63	1.81	0.00	0.26	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	48.64	9.97	16.57	5.83	4.30	3.84	0.77	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	93.25	11.82	57.08	12.54	6.00	5.82	7.45	2.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	33.13	9.52	6.21	5.38	2.90	0.83	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	35.12	8.43	27.81	8.71	2.25	2.25	0.70	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	55.84	7.70	27.34	7.51	4.24	3.08	0.96	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.88	2.78	5.55	1.39	0.69	2.08	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	53.38	8.41	52.86	10.98	3.26	3.43	2.75	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	53.02	8.97	74.76	8.05	6.10	6.10	1.50	1.38
mesenchymal precursor cell - cardiac, donor3	11754-123G8	60.48	14.59	20.03	8.75	3.85	2.52	1.33	1.06
mesenchymal precursor cell - cardiac, donor4	11755-123G9	18.77	7.97	8.91	3.92	1.62	0.95	0.81	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	28.74	14.80	2.99	5.41	3.13	0.85	0.57	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	87.28	20.75	22.07	10.87	5.60	1.32	0.99	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	51.20	20.20	21.17	8.16	3.32	1.52	1.25	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	25.83	14.31	11.52	5.59	0.35	1.05	1.05	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	19.40	8.57	5.10	3.06	2.25	0.41	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	31.99	13.66	5.39	4.67	1.80	0.00	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	46.35	16.76	6.62	6.21	3.10	0.31	0.41	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	6.84	7.30	3.42	2.05	0.68	0.00	0.00	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	17.20	9.23	2.10	2.52	2.10	0.42	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	24.21	8.22	2.99	4.18	1.79	1.20	0.75	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	84.38	28.45	15.06	10.24	6.13	2.54	1.14	1.31
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	82.84	19.14	46.76	9.20	2.58	3.68	1.47	3.68
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	19.46	12.88	3.72	2.29	0.29	0.86	0.86	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	10.53	8.84	0.00	3.37	1.26	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	52.97	8.22	26.03	3.20	2.74	5.94	1.37	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	53.71	12.53	8.95	6.65	2.05	6.39	1.02	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	48.16	11.52	11.78	6.28	5.50	6.02	1.05	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	47.14	7.70	10.17	5.55	4.01	5.85	1.54	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	46.84	6.12	8.71	7.77	4.00	4.47	1.41	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	56.86	6.43	14.55	4.40	3.38	4.06	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	53.44	9.04	13.75	6.29	6.29	4.32	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	55.14	6.49	13.90	3.71	2.78	4.17	0.93	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	48.30	0.00	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	62.59	12.40	9.52	6.63	3.46	4.61	1.15	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	62.47	7.59	10.93	6.69	3.12	5.13	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	59.85	9.61	11.78	6.25	4.81	4.33	0.24	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	90.93	30.80	24.20	6.60	3.67	11.73	3.67	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	54.38	7.38	6.71	5.37	2.01	3.36	1.01	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	56.90	12.28	13.51	5.73	3.68	3.28	1.23	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	55.84	5.58	15.46	6.44	3.01	6.01	1.29	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	65.63	0.00	10.94	0.00	2.73	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	72.31	20.66	20.66	5.16	5.16	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	55.54	8.77	14.62	6.50	2.92	3.90	0.97	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	69.84	10.18	30.55	1.45	2.91	2.91	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	68.23	10.13	30.92	4.26	8.00	3.73	0.53	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	53.16	4.91	21.26	4.09	4.09	4.09	2.45	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	60.25	7.77	17.88	3.89	5.44	5.05	1.55	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	65.06	8.39	23.09	0.00	4.20	10.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	60.60	5.96	12.92	0.99	2.98	7.95	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	81.04	0.00	14.30	4.77	4.77	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	50.99	8.30	10.67	7.12	4.15	4.15	1.78	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	59.70	15.84	30.46	7.31	4.87	3.66	3.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	52.57	9.50	39.27	1.27	5.70	10.13	0.63	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	17.59	5.52	2.07	5.17	3.10	1.03	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	10.75	4.30	6.45	2.15	10.75	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	3.99	7.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	10.33	3.44	0.00	0.00	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	4.07	1.22	1.22	2.85	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	1.59	2.38	7.94	0.79	0.79	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	6.48	2.95	6.48	1.77	0.59	1.77	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	3.43	1.56	9.35	0.94	1.25	0.94	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	9.36	2.67	8.02	0.00	2.67	0.00	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	16.56	5.91	478.98	2.37	1.18	10.64	7.10	14.19
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	0.00	1319.95	0.00	0.00	12.84	15.41	10.27
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.90	4.13	1243.24	3.44	1.38	5.51	6.88	11.70
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	34.64	8.91	8151.96	10.89	1.98	31.17	71.25	93.52
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	34.77	7.85	13455.84	12.34	1.12	26.92	44.86	81.87
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	42.62	8.27	4015.47	4.45	2.54	31.17	54.70	77.60
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	72.13	10.48	7904.92	6.04	5.24	37.07	85.84	156.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	50.15	19.63	15597.74	10.90	0.00	30.53	161.36	220.24
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	65.89	16.47	8386.66	8.87	2.53	44.35	119.10	200.20
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	44.91	10.32	6556.81	7.89	1.21	33.99	61.30	94.67
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	85.86	0.00	20873.13	18.08	0.00	63.27	257.58	289.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	72.48	15.65	17084.78	6.59	3.29	41.18	73.31	116.14
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	28.18	2.78	1700.71	4.17	1.98	16.27	17.06	9.13
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	19.15	4.54	2157.56	3.57	0.65	17.52	27.91	38.61
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	12.22	6.11	6747.39	5.09	4.07	18.34	35.65	40.75
mesodermal tumor cell line:HIRS-BM	10696-109G3	4.64	7.74	0.00	2.32	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	205.53	90.01	35.91	24.10	10.87	5.67	3.31	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	25.72	16.45	3.01	3.24	1.39	0.93	0.00	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	12.82	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	21.17	10.28	0.21	3.29	0.82	0.31	0.10	0.00
mesothelioma cell line:Mero-25	10850-111F4	2.72	4.31	0.00	0.45	0.45	0.00	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	8.56	5.38	0.98	1.47	1.96	0.49	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	8.64	4.65	0.22	0.89	0.44	0.00	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	23.92	15.51	1.05	3.42	0.53	0.79	1.58	0.53
mesothelioma cell line:Mero-83	10854-111F8	57.53	24.17	16.17	3.74	2.89	1.53	0.85	1.87
mesothelioma cell line:Mero-84	10855-111F9	13.14	6.32	0.25	0.76	0.25	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	55.69	20.29	2.48	5.80	4.35	1.04	0.62	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	29.32	19.22	1.49	3.15	2.32	0.17	0.99	0.66
mesothelioma cell line:NCI-H226	10846-111E9	55.38	20.45	6.52	3.80	3.44	0.72	1.63	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	41.68	23.23	3.25	5.12	4.44	0.68	0.34	0.51
mesothelioma cell line:NCI-H28	10845-111E8	32.32	11.45	0.51	4.07	4.58	0.25	1.02	0.00
mesothelioma cell line:No36	10857-111G2	171.58	32.29	4.24	10.44	10.11	1.30	1.63	1.96
mesothelioma cell line:ONE58	10858-111G3	120.57	25.20	31.16	5.15	4.06	2.17	4.06	2.44
migratory langerhans cells, donor1	11901-125F2	37.42	5.57	0.00	4.22	2.11	0.00	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	40.79	6.23	0.00	4.64	3.66	0.00	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	5.03	3.59	0.00	1.08	0.72	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	49.62	14.69	1.31	9.14	5.22	1.31	2.29	2.29
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	28.82	32.21	6.99	6.36	4.03	1.48	1.06	2.54
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	5.30	3.92	0.69	0.69	1.38	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	55.38	10.85	5.52	6.66	5.33	0.38	0.00	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	136.01	29.75	0.00	22.73	12.38	0.55	0.74	1.66
myeloma cell line:PCM6	10474-106I6	219.02	15.81	0.79	20.16	19.37	0.40	0.40	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	359.67	99.94	26.38	33.48	27.39	7.10	0.51	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	95.32	12.55	12.75	7.06	9.22	2.94	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	50.03	19.28	3.01	7.24	2.79	0.33	0.89	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	51.48	16.11	2.28	7.21	3.53	0.44	0.22	0.15
nasal epithelial cells, donor2	12227-129F4	90.53	36.98	8.83	4.97	2.21	2.21	0.55	1.10
neuroblastoma cell line:CHP-134	10508-107D4	63.73	18.86	0.00	28.07	11.96	0.23	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	305.51	50.51	0.94	38.54	31.43	2.81	1.68	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	83.93	44.29	1.90	10.54	11.39	0.42	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	92.06	31.49	0.19	21.43	16.77	0.00	0.56	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	15.18	30.84	0.95	6.41	4.03	0.47	0.24	2.14
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	35.16	15.52	0.79	2.85	5.07	0.63	1.27	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	148.73	33.61	4.63	12.48	21.13	0.60	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	58.49	38.78	3.81	3.18	9.54	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	22.89	6.92	2.13	2.66	1.86	2.40	0.27	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	79.32	16.40	0.00	16.91	9.13	0.00	0.00	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	18.41	10.41	0.00	2.40	0.80	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	5.77	8.66	0.64	0.00	0.96	0.00	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	4.47	5.26	0.79	0.53	1.05	0.26	0.53	0.53
nucleus accumbens, adult, pool1	10037-101F1	119.61	127.58	10.69	20.06	7.97	3.66	1.87	1.12
occipital cortex - adult, donor10196	10172-103C1	140.11	92.72	55.63	10.30	6.18	2.06	4.12	2.06
occipital cortex, adult, donor10252	10163-103B1	103.32	147.33	14.49	24.42	6.44	2.95	3.22	6.71
occipital cortex, newborn, donor10223	10355-105E4	17.47	16.01	8.73	3.64	3.28	1.82	1.46	0.73
occipital lobe, adult, donor1	10076-102A4	110.21	105.22	55.10	18.11	22.57	4.46	24.40	4.99
occipital lobe, fetal, donor1	10073-102A1	29.18	90.54	6.87	11.59	6.87	1.72	2.57	5.15
occipital pole, adult, pool1	10036-101E9	110.93	104.70	8.51	14.74	7.10	2.52	2.37	1.81
olfactory region, adult	10195-103E6	91.13	107.75	44.13	14.14	7.26	3.63	6.11	4.59
optic nerve, donor1	10277-104E7	406.21	302.16	124.06	62.03	28.01	24.01	24.01	14.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	326.92	76.20	6.83	31.10	19.25	2.16	3.19	1.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	329.86	93.56	11.13	22.53	23.77	1.79	0.96	1.10
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	421.11	48.26	41.31	21.33	19.13	6.77	3.22	14.22
oral squamous cell carcinoma cell line:SAS	10544-107H4	39.97	17.21	0.12	9.13	6.24	0.23	0.46	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	14.11	5.88	0.59	2.35	1.18	0.29	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	162.57	61.67	0.00	24.29	24.29	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	360.92	12.30	53.65	9.97	16.12	12.51	4.67	1.06
ovary, adult, pool1	10020-101D2	20.70	20.44	3.76	9.70	2.36	2.88	2.10	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	65.81	26.03	5.32	6.05	6.60	0.73	0.00	0.92
pancreas, adult, donor1	10049-101G4	3.76	5.64	8.47	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	198.19	46.96	4.19	40.81	20.97	0.84	2.52	3.35
papillary adenocarcinoma cell line:8505C	10437-106E5	71.72	26.06	3.24	8.52	2.90	0.68	1.19	3.24
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	115.08	38.58	1.99	15.40	9.27	0.66	0.50	0.50
paracentral gyrus, adult, pool1	10035-101E8	128.22	114.49	10.43	18.49	8.97	2.11	2.93	1.74
parietal cortex, adult, donor10258	10373-105G4	93.22	43.31	8.07	2.94	5.14	0.00	2.20	0.73
parietal lobe - adult, donor10196	10171-103B9	110.98	86.52	21.63	15.05	6.58	1.88	2.82	7.52
parietal lobe, adult, donor10252	10157-103A4	61.57	96.63	7.41	13.68	4.56	1.43	2.85	3.42
parietal lobe, adult, pool1	10034-101E7	144.08	143.81	13.04	23.44	8.90	4.05	3.26	1.06
parietal lobe, fetal, donor1	10072-101I9	41.70	103.77	6.79	7.76	7.76	1.94	2.91	2.91
parietal lobe, newborn, donor10223	10356-105E5	26.92	23.18	7.48	4.11	2.62	3.74	0.37	0.75
parotid gland, adult	10199-103F1	3.70	5.55	342.87	1.23	0.62	1.23	0.62	5.55
penis, adult	10200-103F2	3.22	0.54	119.78	0.54	1.07	0.54	3.22	2.69
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	29.19	30.49	0.56	4.83	4.28	0.37	0.93	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	63.52	23.75	9.32	3.79	4.08	1.02	0.87	0.58
pineal gland - adult, donor10196	10179-103C8	23.87	16.13	36.12	1.94	0.65	1.94	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	13.62	16.58	2.37	1.78	1.18	1.18	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	25.71	13.17	26.96	2.51	2.51	1.88	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	2.02	6.07	1.01	1.01	0.00	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	2.61	9.38	0.00	1.56	1.04	0.00	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	0.85	0.85	0.00	0.00	0.85	0.00	0.85	0.00
placenta, adult, pool1	10021-101D3	7.85	2.37	0.32	1.51	0.86	0.22	0.11	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	40.13	29.80	0.13	12.05	6.36	0.13	0.53	1.46
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	387.39	57.43	63.35	19.77	11.67	12.92	4.20	2.96
pons, adult, pool1	10033-101E6	196.84	143.39	19.71	35.89	11.62	4.56	4.82	2.15
postcentral gyrus, adult, pool1	10032-101E5	117.86	120.13	10.55	17.61	7.50	4.18	2.44	1.05
promyelocytes/myelocytes PMC, donor1	12132-128D8	8.37	0.00	0.00	0.00	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	11.02	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	85.65	60.74	7.14	14.27	8.16	1.31	0.73	1.89
prostate cancer cell line:PC-3	10439-106E7	51.36	54.63	10.16	9.98	3.27	6.72	0.54	0.00
prostate, adult, pool1	10022-101D4	5.71	5.99	0.63	1.72	0.63	0.18	0.00	0.09
putamen, adult, donor10196	10176-103C5	33.52	101.51	5.90	6.37	3.78	2.12	1.18	1.89
putamen, adult, donor10252	10152-102I8	47.06	35.29	5.88	11.76	0.00	3.92	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	75.40	29.51	3.28	7.65	1.09	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	34.55	47.11	11.60	9.42	2.66	2.17	1.45	2.17
putamen, newborn, donor10223	10365-105F5	72.72	44.23	24.74	12.74	4.50	0.75	3.00	2.25
rectal cancer cell line:TT1TKB	10469-106I1	148.38	45.97	2.33	28.51	8.73	0.58	0.87	0.00
rectum, fetal, donor1	10067-101I4	9.74	8.35	25.04	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	21.62	16.54	1.06	2.76	1.70	0.64	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	71.24	46.81	1.24	7.04	4.14	0.41	0.83	0.83
retina, adult, pool1	10030-101E3	28.73	30.42	4.08	7.16	2.98	1.29	1.69	0.40
retinoblastoma cell line:Y79	10475-106I7	45.98	35.07	0.00	33.77	14.03	0.00	1.30	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	129.96	32.83	50.04	6.39	14.88	6.52	1.84	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	424.89	37.12	10.40	44.99	48.09	2.25	0.28	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	38.65	18.95	5.30	3.79	3.79	3.79	0.00	0.00
salivary acinar cells, donor1	11771-123I7	61.99	27.68	5.34	14.41	6.64	1.29	0.97	0.97
salivary acinar cells, donor2	11772-123I8	17.07	8.12	0.69	4.27	2.34	0.14	0.69	0.28
salivary acinar cells, donor3	11773-123I9	91.36	26.48	53.63	11.92	3.97	0.66	0.66	0.00
salivary gland, adult, pool1	10093-102C3	13.15	8.58	17.16	3.43	0.00	0.57	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	169.97	49.91	24.37	22.60	11.38	5.40	5.56	0.84
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	162.22	62.42	27.27	19.51	10.70	8.11	4.23	1.18
seminal vesicle, adult	10201-103F3	1.06	3.17	28.57	1.59	0.00	0.53	1.59	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	99.11	20.41	1.94	9.96	3.40	0.24	1.70	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	63.66	8.30	3.27	4.78	4.53	0.50	0.00	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	8.03	3.01	1.00	3.01	1.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	5.24	6.85	0.13	0.40	0.54	0.00	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	18.46	15.47	1.55	2.87	1.22	0.88	0.11	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	133.93	33.68	28.00	9.68	6.58	14.32	0.90	1.42
skeletal muscle - soleus muscle, donor1	10282-104F3	0.00	0.00	4.97	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	0.60	1.08	31.90	0.36	0.36	0.00	4.68	0.36
skeletal muscle, fetal, donor1	10066-101I3	4.02	4.02	309.54	3.02	2.01	2.01	0.00	3.02
skin, adult, donor1	10074-102A2	13.57	0.00	33.93	13.57	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	24.62	8.21	5898.82	2.52	2.52	16.41	81.43	54.29
small cell cervical cancer cell line:HCSC-1	10800-110I8	333.52	69.37	39.36	23.01	31.68	4.34	6.67	2.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	26.48	30.26	0.95	5.67	3.15	2.52	0.32	2.52
small cell lung carcinoma cell line:DMS 144	10841-111E4	4.63	116.03	0.19	3.66	0.96	0.39	0.39	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	34.78	20.60	0.00	15.82	8.57	0.16	0.16	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	35.87	82.19	0.32	27.67	5.47	0.32	2.09	4.02
small cell lung carcinoma cell line:WA-hT	10562-108A4	9.37	26.15	0.00	3.92	1.53	1.09	0.44	0.22
small intestine, adult, pool1	10024-101D6	35.36	10.03	5.49	6.09	1.91	13.50	1.43	0.24
small intestine, fetal, donor1	10064-101I1	6.63	6.14	2.70	1.23	0.49	0.00	0.00	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	17.44	14.87	1.03	6.15	1.03	0.51	1.03	0.51
smooth muscle, adult, pool1	10048-101G3	1.55	2.58	24.81	1.29	0.00	0.00	0.52	0.52
somatostatinoma cell line:QGP-1	10781-110G7	89.52	36.18	0.54	9.65	5.90	0.00	0.80	0.27
spinal cord - adult, donor10196	10181-103D1	254.87	216.56	78.23	40.83	17.66	15.37	15.37	22.25
spinal cord, adult, donor10252	10159-103A6	216.06	246.42	10.25	46.92	13.01	4.73	14.59	5.13
spinal cord, adult, donor10258	10369-105F9	390.87	127.98	33.90	24.90	8.99	0.00	9.69	9.69
spinal cord, fetal, donor1	10056-101H2	151.24	145.75	551.29	28.66	18.30	8.54	6.71	12.81
spinal cord, newborn, donor10223	10359-105E8	212.16	85.41	56.94	18.83	11.48	6.43	5.05	7.81
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	13.59	12.10	2.54	1.79	1.49	0.75	0.15	0.15
spleen, adult, pool1	10025-101D7	11.45	7.38	0.33	3.52	1.10	0.22	0.00	0.33
spleen, fetal, pool1	10044-101F8	8.42	7.31	2.15	2.38	1.11	0.48	0.08	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	100.92	39.02	0.21	15.53	9.32	0.10	0.62	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	11.20	7.22	0.19	1.33	0.76	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	220.85	37.04	6.29	23.06	17.82	2.80	4.54	6.29
squamous cell carcinoma cell line:T3M-5	10616-108G4	5.86	11.73	0.39	1.95	0.00	0.39	0.00	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	27.13	38.83	0.11	4.28	2.14	0.56	0.79	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	23.72	5.93	1.69	3.39	2.12	0.00	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	173.88	19.46	39.77	28.77	21.15	3.81	0.00	1.27
stomach, fetal, donor1	10062-101H8	7.48	13.88	3.20	2.14	0.00	3.20	0.00	2.14
submaxillary gland, adult	10202-103F4	9.68	6.84	42.16	2.28	0.00	0.57	0.57	1.14
substantia nigra - adult, donor10196	10178-103C7	1031.21	379.92	162.82	162.82	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	209.16	238.86	17.86	34.69	11.63	6.02	11.01	11.22
substantia nigra, adult, donor10258	10371-105G2	206.90	79.66	22.24	8.79	6.72	1.03	3.62	1.03
substantia nigra, newborn, donor10223	10358-105E7	156.15	60.06	40.27	14.84	14.13	4.95	4.95	5.65
synovial sarcoma cell line:HS-SY-II	10441-106E9	236.37	69.93	44.71	30.26	34.85	7.34	2.06	0.69
temporal lobe, adult, pool1	10031-101E4	126.31	130.21	12.12	20.18	8.22	3.98	3.65	2.03
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	17.09	92.59	6.41	7.12	2.85	2.85	2.14	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	18.46	67.25	2.64	5.27	2.20	0.88	0.88	2.64
tenocyte, donor1	11763-123H8	15.01	9.08	1.40	3.49	0.70	1.05	0.00	1.40
tenocyte, donor2	11765-123I1	2.67	0.38	0.00	1.14	0.38	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	1.85	1.48	0.00	1.11	0.00	0.00	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	308.82	53.20	3.40	37.39	62.04	2.04	3.06	1.36
teratocarcinoma cell line:NCR-G1	10798-110I6	273.77	55.19	2.16	19.42	25.28	1.23	2.93	1.85
teratocarcinoma cell line:PA-1	10807-111A6	432.23	58.12	19.84	34.41	64.16	2.01	2.01	2.32
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	268.62	41.13	2.16	30.72	40.37	0.89	1.78	1.40
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	8.32	7.19	0.00	4.16	2.65	0.00	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	55.19	23.88	0.11	31.19	12.32	0.44	1.09	0.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	75.24	34.20	0.98	21.82	15.63	0.98	3.58	3.91
testis, adult, pool1	10026-101D8	38.01	10.84	0.97	11.70	3.11	0.75	3.33	0.54
testis, adult, pool2	10096-102C6	102.85	16.69	6.32	11.73	5.86	0.45	1.35	2.26
thalamus - adult, donor10196	10168-103B6	291.45	189.89	103.77	27.60	8.83	3.31	16.56	6.62
thalamus, adult, donor10252	10154-103A1	215.67	206.45	26.10	38.91	10.16	4.69	12.03	12.66
thalamus, adult, donor10258, tech_rep1	10370-105G1	312.54	78.52	23.09	9.24	4.62	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	102.77	73.29	47.10	15.15	5.76	3.46	5.43	3.62
thalamus, newborn, donor10223	10366-105F6	81.70	30.49	24.16	10.36	10.36	0.58	2.30	1.15
throat, adult	10209-103G2	17.23	5.74	38.20	2.25	1.75	0.25	2.25	2.50
throat, fetal, donor1	10061-101H7	1.52	3.35	4.27	0.61	0.00	0.30	0.00	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	8.94	83.27	0.60	3.58	3.78	0.00	0.40	0.99
thymus, adult, pool1	10027-101D9	9.54	10.44	0.10	4.08	1.59	0.00	0.30	0.20
thymus, fetal, pool1	10043-101F7	15.17	12.88	1.66	3.84	1.35	0.52	0.21	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	51.99	12.37	0.53	4.39	3.19	0.13	0.53	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	46.38	49.87	16.06	7.82	3.35	0.98	1.26	0.98
thyroid, adult, pool1	10028-101E1	1.59	0.75	0.56	0.75	0.19	0.09	0.00	0.00
thyroid, fetal, donor1	10060-101H6	1.58	2.90	23.99	0.53	0.00	0.26	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	9.24	0.00	3.08	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	45.35	8.84	8.61	6.05	3.26	0.23	0.93	2.09
tongue, fetal, donor1	10059-101H5	9.46	7.49	87.88	0.39	0.79	0.00	0.39	3.15
tonsil, adult, pool1	10047-101G2	26.85	14.02	1.10	4.71	1.80	0.40	0.30	0.10
trachea, adult, pool1	10029-101E2	18.16	8.43	6.30	3.60	1.31	0.49	0.16	0.16
trachea, fetal, donor1	10058-101H4	7.31	8.08	19.62	0.00	1.15	0.00	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	9.92	5.31	1.77	1.42	1.06	0.71	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	65.35	28.77	0.81	9.32	6.69	0.61	0.91	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	68.94	36.82	21.15	19.59	6.27	1.72	1.88	0.94
tridermal teratoma cell line:HGRT	10694-109G1	7.61	20.93	0.00	5.71	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	79.06	14.90	27.93	7.28	8.80	12.78	1.19	0.08
umbilical cord, fetal, donor1	10057-101H3	43.82	10.43	191.96	2.09	2.09	0.00	4.17	0.00
uterus, adult, pool1	10100-102D1	4.27	4.10	1.02	1.71	0.68	0.17	0.00	0.00
uterus, fetal, donor1	10055-101H1	44.03	22.52	28.16	6.66	1.02	2.05	0.00	1.54
vagina, adult	10204-103F6	6.46	5.17	6.46	2.58	0.65	1.94	0.00	0.65
vein, adult	10191-103E2	6.80	2.41	153.88	2.41	0.88	2.63	5.70	8.11
xeroderma pigentosum b cell line:XPL 17	10563-108A5	64.89	15.49	0.00	9.08	4.81	0.00	0.00	0.80